Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ischemic Heart Disease

  Free Subscription

Articles published in
J Am Coll Cardiol
    July 2018
  1. GRANGER CB, Kochar A
    Understanding and Targeting Inflammation in Acute Myocardial Infarction: An Elusive Goal.
    J Am Coll Cardiol. 2018;72:199-201.
    >> Share

  2. LEVY B, Clere-Jehl R, Legras A, Morichau-Beauchant T, et al
    Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction.
    J Am Coll Cardiol. 2018;72:173-182.
    >> Share

  3. MOHOLDT T, Lavie CJ, Nauman J
    Reply: Physical Activity to Reduce Weight and Cardiovascular Events: A Wrong Focus Regarding a Shiver Contention.
    J Am Coll Cardiol. 2018;72:239.
    >> Share

  4. LEGGIO M, D'Emidio S, Fusco A, Bendini MG, et al
    Physical Activity to Reduce Weight and Cardiovascular Events: A Wrong Focus Regarding a Shiver Contention.
    J Am Coll Cardiol. 2018;72:238-239.
    >> Share

  5. SCHNEIDER DJ, McMahon SR, Chava S, Taatjes-Sommer HS, et al
    FcgammaRIIa: A New Cardiovascular Risk Marker.
    J Am Coll Cardiol. 2018;72:237-238.
    >> Share

  6. SAEED A, Feofanova EV, Yu B, Sun W, et al
    Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease.
    J Am Coll Cardiol. 2018;72:156-169.
    >> Share

  7. GIBSON CM, Levitan B, Gibson WJ, Yee MK, et al
    Fatal or Irreversible Bleeding and Ischemic Events With Rivaroxaban in Acute Coronary Syndrome.
    J Am Coll Cardiol. 2018;72:129-136.
    >> Share

  8. HOHNLOSER SH, Eikelboom JW
    Direct Oral Anticoagulants and Myocardial Infarction: The Dust Is Settling.
    J Am Coll Cardiol. 2018;72:27-28.
    >> Share

  9. LEE CJ, Gerds TA, Carlson N, Bonde AN, et al
    Risk of Myocardial Infarction in Anticoagulated Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:17-26.
    >> Share

  10. PRABHAKARAN D, Singh K, Roth GA, Banerjee A, et al
    Cardiovascular Diseases in India Compared With the United States.
    J Am Coll Cardiol. 2018;72:79-95.
    >> Share

  11. GHOSSEIN-DOHA C, Hooijschuur MCE, Spaanderman MEA
    Pre-Eclampsia: A Twilight Zone Between Health and Cardiovascular Disease?
    J Am Coll Cardiol. 2018;72:12-16.
    >> Share

    June 2018
  12. GAUDINO M, Mack MJ, Taggart DP
    Additional Arterial Conduits in Coronary Artery Bypass Surgery: Finally Coming of Age.
    J Am Coll Cardiol. 2018;71:2974-2976.
    >> Share

  13. MUELLERLEILE K, Lund GK
    Cardiovascular Magnetic Resonance in Cardiac Amyloidosis: T1 Is Not Enough.
    J Am Coll Cardiol. 2018;71:2932-2934.
    >> Share

  14. LIU G, Li Y, Hu Y, Zong G, et al
    Influence of Lifestyle on Incident Cardiovascular Disease and Mortality in Patients With Diabetes Mellitus.
    J Am Coll Cardiol. 2018;71:2867-2876.
    >> Share

  15. TURAGAM MK, Velagapudi P, Kar S, Holmes D, et al
    Cardiovascular Therapies Targeting Left Atrial Appendage.
    J Am Coll Cardiol. 2018 Jun 25. pii: S0735-1097(18)35139.
    >> Share

  16. PINHO-GOMES AC, Azevedo L, Taggart DP
    Reply: Optimal Guideline-Directed Medical Therapy for Patients With Stable Ischemic Heart Disease.
    J Am Coll Cardiol. 2018;71:2862-2863.
    >> Share

  17. SHAH R
    Optimal Guideline-Directed Medical Therapy for Patients With Stable Ischemic Heart Disease.
    J Am Coll Cardiol. 2018;71:2861-2862.
    >> Share

  18. HOSHIDE S, Yano Y, Kanegae H, Kario K, et al
    Effect of Lowering Home Blood Pressure on Subclinical Cardiovascular Disease in Masked Uncontrolled Hypertension.
    J Am Coll Cardiol. 2018;71:2858-2859.
    >> Share

  19. O'LONE E, Viecelli AK, Craig JC, Tong A, et al
    Cardiovascular Outcomes Reported in Hemodialysis Trials.
    J Am Coll Cardiol. 2018;71:2802-2810.
    >> Share

  20. ODQVIST M, Andersson PO, Tygesen H, Eggers KM, et al
    High-Sensitivity Troponins and Outcomes After Myocardial Infarction.
    J Am Coll Cardiol. 2018;71:2616-2624.
    >> Share

  21. MOTOVSKA Z, Hlinomaz O, Kala P
    Reply: Cost of Therapies in Acute Coronary Syndromes: A Relevant Factor Not Reflected in the Trials.
    J Am Coll Cardiol. 2018;71:2711-2712.
    >> Share

  22. LOZANO I, Lopez-Palop R, Garcia Rubio J, Cordero A, et al
    Cost of Therapies in Acute Coronary Syndromes: A Relevant Factor Not Reflected in the Trials.
    J Am Coll Cardiol. 2018;71:2710.
    >> Share

  23. KIM JM, Stewart R, Kim JW, Kang HJ, et al
    Serotonin Transporter Gene Association Between Anxiety and Long-Term Cardiac Outcomes in Acute Coronary Syndromes.
    J Am Coll Cardiol. 2018;71:2706-2707.
    >> Share

  24. HAN JJ, Brown CR
    The Heart Team: A Powerful Paradigm for the Future Training of Cardiovascular Surgeons.
    J Am Coll Cardiol. 2018;71:2702-2705.
    >> Share

  25. GOODING HC, Ning H, Gillman MW, Allen N, et al
    Predicting Cardiovascular Health in Coronary Artery Risk Development in Young Adults.
    J Am Coll Cardiol. 2018;71:2601-2602.
    >> Share

  26. BAGGETT TP, Liauw SS, Hwang SW
    Cardiovascular Disease and Homelessness.
    J Am Coll Cardiol. 2018;71:2585-2597.
    >> Share

  27. MILLER VM, Mankad R
    Sex Steroids and Incident Cardiovascular Disease in Post-Menopausal Women: New Perspective on an Old Controversy.
    J Am Coll Cardiol. 2018;71:2567-2569.
    >> Share

  28. ZHAO D, Guallar E, Ouyang P, Subramanya V, et al
    Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women.
    J Am Coll Cardiol. 2018;71:2555-2566.
    >> Share

  29. CHANG HJ, Lin FY, Lee SE, Andreini D, et al
    Coronary Atherosclerotic Precursors of Acute Coronary Syndromes.
    J Am Coll Cardiol. 2018;71:2511-2522.
    >> Share

  30. CAVENDER MA, Norhammar A, Birkeland KI, Jorgensen ME, et al
    SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL.
    J Am Coll Cardiol. 2018;71:2497-2506.
    >> Share

    May 2018
  31. SINGH A, DiCarli MF, Nasir K, Bhatt DL, et al
    Reply: Cardiovascular Risk Models and Statin Therapy.
    J Am Coll Cardiol. 2018;71:2491-2492.
    >> Share

  32. DUBROFF RJ
    Cardiovascular Risk Models and Statin Therapy.
    J Am Coll Cardiol. 2018;71:2490-2491.
    >> Share

  33. BLAHA MJ, Nasir K, Budoff MJ, Dardari ZA, et al
    Impact of C-Reactive Protein and Coronary Artery Calcium on Benefit Observed With Atorvastatin.
    J Am Coll Cardiol. 2018;71:2487-2488.
    >> Share

  34. CHERNEY DZI, Lytvyn Y, McCullough PA
    Cardiovascular Risk Reduction in Patients With Chronic Kidney Disease: Potential for Targeting Inflammation With Canakinumab.
    J Am Coll Cardiol. 2018;71:2415-2418.
    >> Share

  35. RIDKER PM, MacFadyen JG, Glynn RJ, Koenig W, et al
    Inhibition of Interleukin-1beta by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease.
    J Am Coll Cardiol. 2018;71:2405-2414.
    >> Share

  36. PINA IL, Di Palo KE, Ventura HO
    Psychopharmacology and Cardiovascular Disease.
    J Am Coll Cardiol. 2018;71:2346-2359.
    >> Share

  37. FORMAN DE, Maurer MS, Boyd C, Brindis R, et al
    Multimorbidity in Older Adults With Cardiovascular Disease.
    J Am Coll Cardiol. 2018;71:2149-2161.
    >> Share

  38. SIASOS G, Sara JD, Zaromytidou M, Park KH, et al
    Local Low Shear Stress and Endothelial Dysfunction in Patients With Nonobstructive Coronary Atherosclerosis.
    J Am Coll Cardiol. 2018;71:2092-2102.
    >> Share

  39. SCIARRETTA S, Yee D, Nagarajan N, Bianchi F, et al
    Trehalose-Induced Activation of Autophagy Improves Cardiac Remodeling After Myocardial Infarction.
    J Am Coll Cardiol. 2018;71:1999-2010.
    >> Share

  40. MADHAVAN MV, Gersh BJ, Alexander KP, Granger CB, et al
    Coronary Artery Disease in Patients >/=80 Years of Age.
    J Am Coll Cardiol. 2018;71:2015-2040.
    >> Share

  41. COLLERAN R, Kufner S, Mehilli J, Rosenbeiger C, et al
    Efficacy Over Time With Drug-Eluting Stents in Saphenous Vein Graft Lesions.
    J Am Coll Cardiol. 2018;71:1973-1982.
    >> Share

  42. SCOTT PE, Unger EF, Jenkins MR, Southworth MR, et al
    Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs.
    J Am Coll Cardiol. 2018;71:1960-1969.
    >> Share

  43. DEVGUN JK, Gul S, Mohananey D, Jones BM, et al
    Cerebrovascular Events After Cardiovascular Procedures: Risk Factors, Recognition, and Prevention Strategies.
    J Am Coll Cardiol. 2018;71:1910-1920.
    >> Share

  44. MONGRAW-CHAFFIN M, Foster MC, Anderson CAM, Burke GL, et al
    Metabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular Risk.
    J Am Coll Cardiol. 2018;71:1857-1865.
    >> Share

    April 2018
  45. HIRSHFELD JW JR, Ferrari VA, Bengel FM, Bergersen L, et al
    2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging-Best Practices for Safety and Effectiveness, Part 2: Radiological Equipment Operation, Dose-Sparing Methodologies, Patient and Medica
    J Am Coll Cardiol. 2018 Apr 30. pii: S0735-1097(18)33224.
    >> Share

  46. HIRSHFELD JW JR, Ferrari VA, Bengel FM, Bergersen L, et al
    2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging: Best Practices for Safety and Effectiveness: A Report of the American College of Cardiology Task Force on Expert Consensus Decision
    J Am Coll Cardiol. 2018 Apr 30. pii: S0735-1097(18)33222.
    >> Share

  47. HIRSHFELD JW JR, Ferrari VA, Bengel FM, Bergersen L, et al
    2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging-Best Practices for Safety and Effectiveness, Part 1: Radiation Physics and Radiation Biology.
    J Am Coll Cardiol. 2018 Apr 30. pii: S0735-1097(18)33223.
    >> Share

  48. PETERS SAE, Colantonio LD, Zhao H, Bittner V, et al
    Sex Differences in High-Intensity Statin Use Following Myocardial Infarction in the United States.
    J Am Coll Cardiol. 2018;71:1729-1737.
    >> Share

  49. RAZVI S, Jabbar A, Pingitore A, Danzi S, et al
    Thyroid Hormones and Cardiovascular Function and Diseases.
    J Am Coll Cardiol. 2018;71:1781-1796.
    >> Share

  50. PARK DW, Lee PH, Jang S, Lim HS, et al
    Effect of Low-Dose Versus Standard-Dose Ticagrelor and Clopidogrel on Platelet Inhibition in Acute Coronary Syndromes.
    J Am Coll Cardiol. 2018;71:1594-1595.
    >> Share

  51. GAL D, Thijs B, Glanzel W, Sipido KR, et al
    A Changing Landscape in Cardiovascular Research Publication Output: Bridging the Translational Gap.
    J Am Coll Cardiol. 2018;71:1584-1589.
    >> Share

  52. IVEY KS, Edwards KM, Talbot HK
    Respiratory Syncytial Virus and Associations With Cardiovascular Disease in Adults.
    J Am Coll Cardiol. 2018;71:1574-1583.
    >> Share

    March 2018
  53. YUDI MB, Sharma SK, Tang GHL, Kini A, et al
    Coronary Angiography and Percutaneous Coronary Intervention After Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2018;71:1360-1378.
    >> Share

  54. EDSTEDT BONAMY AK, Carr H
    Cardiovascular Stress Test in People Born Preterm: A Peephole Into the Future.
    J Am Coll Cardiol. 2018;71:1357-1359.
    >> Share

  55. NESTELBERGER T, Boeddinghaus J, Badertscher P, Twerenbold R, et al
    Reply: Clarifying the Proper Definitions for Type 2 Myocardial Infarction.
    J Am Coll Cardiol. 2018;71:1291-1292.
    >> Share

  56. THYGESEN K, Alpert JS, Jaffe AS, Chaitman BR, et al
    Clarifying the Proper Definitions for Type 2 Myocardial Infarction.
    J Am Coll Cardiol. 2018;71:1291.
    >> Share

  57. WU CK, Juang JJ, Chiang JY, Li YH, et al
    The Taiwan Heart Registries: Its Influence on Cardiovascular Patient Care.
    J Am Coll Cardiol. 2018;71:1273-1283.
    >> Share

  58. SCHMIDT M, Maeng M, Madsen M, Sorensen HT, et al
    The Western Denmark Heart Registry: Its Influence on Cardiovascular Patient Care.
    J Am Coll Cardiol. 2018;71:1259-1272.
    >> Share

  59. GARGIULO G, Carrara G, Frigoli E, Vranckx P, et al
    Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes.
    J Am Coll Cardiol. 2018;71:1231-1242.
    >> Share

  60. VALENTINE CM
    Tackling the Quadruple Aim: Helping Cardiovascular Professionals Find Work-Life Balance.
    J Am Coll Cardiol. 2018 Mar 15. pii: S0735-1097(18)33539.
    >> Share

  61. MOHOLDT T, Lavie CJ, Nauman J
    Sustained Physical Activity, Not Weight Loss, Associated With Improved Survival in Coronary Heart Disease.
    J Am Coll Cardiol. 2018;71:1094-1101.
    >> Share

  62. GAUDINO M, Burzotta F, Bakaeen F, Bertrand O, et al
    The Radial Artery for Percutaneous Coronary Procedures or Surgery?
    J Am Coll Cardiol. 2018;71:1167-1175.
    >> Share

  63. KAZI DS
    Building the Economic Case for Investment in Cardiovascular Prevention.
    J Am Coll Cardiol. 2018;71:1090-1093.
    >> Share

  64. SHAW LJ, Goyal A, Mehta C, Xie J, et al
    10-Year Resource Utilization and Costs for Cardiovascular Care.
    J Am Coll Cardiol. 2018;71:1078-1089.
    >> Share

  65. GREENE SJ, Vaduganathan M, Khan MS, Bakris GL, et al
    Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients With Type 2 Diabetes.
    J Am Coll Cardiol. 2018 Mar 10. pii: S0735-1097(18)30326.
    >> Share

  66. KOSIBOROD M, Lam CSP, Kohsaka S, Kim DJ, et al
    Lower Cardiovascular Risk Associated with SGLT-2i in >400,000 Patients: The CVD-REAL 2 Study.
    J Am Coll Cardiol. 2018 Mar 7. pii: S0735-1097(18)33528.
    >> Share

  67. LIU A, Wijesurendra RS, Liu JM, Greiser A, et al
    Gadolinium-Free Cardiac MR Stress T1-Mapping to Distinguish Epicardial From Microvascular Coronary Disease.
    J Am Coll Cardiol. 2018;71:957-968.
    >> Share

  68. DICKERT NW, Wendler D, Devireddy CM, Goldkind SF, et al
    Consent for Pragmatic Trials in Acute Myocardial Infarction.
    J Am Coll Cardiol. 2018;71:1051-1053.
    >> Share

  69. KIM SC, Neogi T, Kang EH, Liu J, et al
    Cardiovascular Risks of Probenecid Versus Allopurinol in Older Patients With Gout.
    J Am Coll Cardiol. 2018;71:994-1004.
    >> Share

  70. SMART NA, Dieberg G, King N
    Long-Term Outcomes of On- Versus Off-Pump Coronary Artery Bypass Grafting.
    J Am Coll Cardiol. 2018;71:983-991.
    >> Share

  71. KARAMITSOS TD
    Mapping the Future of Myocardial Ischemia Testing With Cardiac Magnetic Resonance.
    J Am Coll Cardiol. 2018;71:980-982.
    >> Share

  72. LIKOSKY DS, Sukul D, Seth M, He C, et al
    Association Between Medicaid Expansion and Cardiovascular Interventions in Michigan.
    J Am Coll Cardiol. 2018;71:1050-1051.
    >> Share

  73. DAABOUL Y, Korjian S, Plotnikov AN, Burton P, et al
    Rivaroxaban and Post-Stroke Neurological Outcomes in Patients With Acute Coronary Syndrome.
    J Am Coll Cardiol. 2018;71:1048-1049.
    >> Share

  74. HICKS KA, Mahaffey KW, Mehran R, Nissen SE, et al
    2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.
    J Am Coll Cardiol. 2018;71:1021-1034.
    >> Share

  75. GIVERTZ MM
    Treating Gout in Patients With Cardiovascular Disease: Mutual Benefit or Unintended Consequences?
    J Am Coll Cardiol. 2018;71:1005-1008.
    >> Share

  76. DEFILIPPIS EM, Singh A, Divakaran S, Gupta A, et al
    Cocaine and Marijuana Use among Young Adults Presenting with Myocardial Infarction: The Partners YOUNG-MI Registry.
    J Am Coll Cardiol. 2018 Mar 5. pii: S0735-1097(18)33383.
    >> Share

  77. SAEED A, Nambi V, Sun W, Virani SS, et al
    Short-Term Global Cardiovascular Disease Risk Prediction in Older Adults.
    J Am Coll Cardiol. 2018 Mar 3. pii: S0735-1097(18)33484.
    >> Share

  78. PHILLIPS RA, Xu J, Peterson LE, Arnold RM, et al
    Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension.
    J Am Coll Cardiol. 2018 Mar 2. pii: S0735-1097(18)33226.
    >> Share

    February 2018
  79. LEE JM, Rhee TM, Hahn JY, Kim HK, et al
    Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock.
    J Am Coll Cardiol. 2018;71:844-856.
    >> Share

  80. KUMAR V, Gopalakrishnan L, Singh M, Singh S, et al
    Effect of Cocaine on Coronary Microvasculature.
    J Am Coll Cardiol. 2018;71:954-955.
    >> Share

  81. LEE PH, Kwon O, Ahn JM, Lee CH, et al
    Safety and Effectiveness of Second-Generation Drug-Eluting Stents in Patients With Left Main Coronary Artery Disease.
    J Am Coll Cardiol. 2018;71:832-841.
    >> Share

  82. NAGENDRAN J, Bozso SJ, Norris CM, McAlister FA, et al
    Coronary Artery Bypass Surgery Improves Outcomes in Patients With Diabetes and Left Ventricular Dysfunction.
    J Am Coll Cardiol. 2018;71:819-827.
    >> Share

  83. NOTARANGELO FM, Maglietta G, Bevilacqua P, Cereda M, et al
    Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Acute Coronary Syndromes: PHARMCLO trial.
    J Am Coll Cardiol. 2018 Feb 24. pii: S0735-1097(18)33306.
    >> Share

  84. FERREIRA JP, Girerd N, Gregson J, Latar I, et al
    Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:727-735.
    >> Share

  85. STURGISS EA, Agostino J
    Preventive Health Care Should Focus on Modifiable Cardiovascular Risk Factors, Not Obesity Alone.
    J Am Coll Cardiol. 2018;71:815-816.
    >> Share

  86. LEGGIO M, Sgorbini L, Limongelli G
    Metabolically Healthy Obese and Cardiovascular Diseases: A Phenotype Misunderstanding.
    J Am Coll Cardiol. 2018;71:813-814.
    >> Share

  87. PUNTMANN VO, Carr-White G, Jabbour A, Yu CY, et al
    Native T1 and ECV of Noninfarcted Myocardium and Outcome in Patients With Coronary Artery Disease.
    J Am Coll Cardiol. 2018;71:766-778.
    >> Share

  88. KOSMIDOU I, Chen S, Kappetein AP, Serruys PW, et al
    New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.
    J Am Coll Cardiol. 2018;71:739-748.
    >> Share

  89. HOLMES MV, Millwood IY, Kartsonaki C, Hill MR, et al
    Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke.
    J Am Coll Cardiol. 2018;71:620-632.
    >> Share

  90. PASTORI D, Nocella C, Farcomeni A, Bartimoccia S, et al
    Reply: LDL-Cholesterol and Atherosclerotic Cardiovascular Disease: Innocent Bystander or Essential Ingredient?
    J Am Coll Cardiol. 2018;71:706-707.
    >> Share

  91. EGOM EE
    LDL-Cholesterol and Atherosclerotic Cardiovascular Disease: Innocent Bystander or Essential Ingredient.
    J Am Coll Cardiol. 2018;71:705-706.
    >> Share

  92. MOUSSEAUX E, Agoston-Coldea L, Marjanovic Z, Stanciu R, et al
    Left Ventricle Replacement Fibrosis Detected by CMR Associated With Cardiovascular Events in Systemic Sclerosis Patients.
    J Am Coll Cardiol. 2018;71:703-705.
    >> Share

  93. MCGLINCHEY EL, Oyesiku L, Diaz KM, Ye S, et al
    Impact of Sleep Duration and Race on Recurrent Cardiovascular Events Following Acute Coronary Syndrome.
    J Am Coll Cardiol. 2018;71:701-703.
    >> Share

  94. MUNZEL T, Schmidt FP, Steven S, Herzog J, et al
    Environmental Noise and the Cardiovascular System.
    J Am Coll Cardiol. 2018;71:688-697.
    >> Share

  95. MAYR M, Gerszten R, Kiechl S
    Cardiovascular Risk Beyond Low-Density Lipoprotein Cholesterol.
    J Am Coll Cardiol. 2018;71:633-635.
    >> Share

  96. RUEL M, Kulik A
    Suboptimal Medical Therapy After Coronary Revascularization: A Missed Opportunity.
    J Am Coll Cardiol. 2018;71:603-605.
    >> Share

  97. PINHO-GOMES AC, Azevedo L, Ahn JM, Park SJ, et al
    Compliance With Guideline-Directed Medical Therapy in Contemporary Coronary Revascularization Trials.
    J Am Coll Cardiol. 2018;71:591-602.
    >> Share

  98. BANSILAL S, Bonaca MP, Cornel JH, Storey RF, et al
    Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease.
    J Am Coll Cardiol. 2018;71:489-496.
    >> Share

  99. ZHAO M, Veeranki SP, Xi B
    Reply: Alcohol: Cardiovascular Disease and Cancer.
    J Am Coll Cardiol. 2018;71:583-584.
    >> Share

  100. BRAILLON A
    Alcohol: Cardiovascular Disease and Cancer.
    J Am Coll Cardiol. 2018;71:582-583.
    >> Share

  101. FRY ETA, Walsh MN
    Cardiovascular Health System Leadership: An Evolving Model.
    J Am Coll Cardiol. 2018;71:575-576.
    >> Share

  102. KISHORE SP, Blank E, Heller DJ, Patel A, et al
    Modernizing the World Health Organization List of Essential Medicines for Preventing and Controlling Cardiovascular Diseases.
    J Am Coll Cardiol. 2018;71:564-574.
    >> Share

  103. BLANKSTEIN R, Shaw LJ, Di Carli MF
    Coronary Plaque Volume and Stenosis: Important Determinants of Myocardial Ischemia.
    J Am Coll Cardiol. 2018;71:510-512.
    >> Share

  104. LEE MS, Tanoue MT
    Impact of Ticagrelor in Patients With Prior MI and MVD for Reducing Cardiovascular Events.
    J Am Coll Cardiol. 2018;71:497-498.
    >> Share

    January 2018
  105. SAW J, Humphries K, Mancini GBJ
    Reply: Should We Recommend Cardiac Rehabilitation in Patients With Spontaneous Coronary Artery Dissection?
    J Am Coll Cardiol. 2018;71:473.
    >> Share

  106. KRITTANAWONG C, Rozanski A, Palazzo A
    Should We Recommend Cardiac Rehabilitation in Patients With Spontaneous Coronary Artery Dissection?
    J Am Coll Cardiol. 2018;71:472-473.
    >> Share

  107. TWEET MS, Hayes SN, Codsi E, Gulati R, et al
    Reply: Sex, Gender, and Reproductive History Are Critical Variables for Spontaneous Coronary Artery Dissection Research.
    J Am Coll Cardiol. 2018;71:471-472.
    >> Share

  108. SAW J
    Reply: Pregnancy-Associated Coronary Artery Dissection: A Therapeutic Dilemma.
    J Am Coll Cardiol. 2018;71:470-471.
    >> Share

  109. ELKAYAM U, Havakuk O
    Pregnancy-Associated Coronary Artery Dissection: A Therapeutic Dilemma.
    J Am Coll Cardiol. 2018;71:469-470.
    >> Share

  110. MACAYA F, Salinas P, Garcia-Gonzalez C, Gonzalo N, et al
    Pregnancy-Associated Spontaneous Coronary Artery Dissection: A Different Presentation Although Perhaps Not Such a Distinct Condition.
    J Am Coll Cardiol. 2018;71:468-469.
    >> Share

  111. KRITTANAWONG C, Yue B
    The Difficulty in Identifying Pregnancy-Associated Coronary Artery Dissection Using Nationwide Inpatient Databases.
    J Am Coll Cardiol. 2018;71:468.
    >> Share

  112. MENASCHE P, Vanneaux V, Hagege A, Bel A, et al
    Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction.
    J Am Coll Cardiol. 2018;71:429-438.
    >> Share

  113. CHATZIZISIS YS, Stefanadis C
    Clash of Oral P2Y12 Receptor Inhibitors in Acute Coronary Syndromes.
    J Am Coll Cardiol. 2018;71:382-385.
    >> Share

  114. THACKERAY JT, Hupe HC, Wang Y, Bankstahl JP, et al
    Myocardial Inflammation Predicts Remodeling and Neuroinflammation After Myocardial Infarction.
    J Am Coll Cardiol. 2018;71:263-275.
    >> Share

  115. FITCHETT D, Inzucchi SE, Lachin JM, Wanner C, et al
    Cardiovascular Mortality Reduction With Empagliflozin in Patients With Type 2 Diabetes and Cardiovascular Disease.
    J Am Coll Cardiol. 2018;71:364-367.
    >> Share

  116. O'GALLAGHER K, Khan F, Omar SA, Kalra S, et al
    Inorganic Nitrite Selectively Dilates Epicardial Coronary Arteries.
    J Am Coll Cardiol. 2018;71:363-364.
    >> Share

  117. MEHTA SR, Anand SS
    Identifying and Treating Young Patients at Risk for Cardiovascular Events.
    J Am Coll Cardiol. 2018;71:303-305.
    >> Share

  118. D'ERASMO L, Minicocci I, Nicolucci A, Pintus P, et al
    Autosomal Recessive Hypercholesterolemia: Long-Term Cardiovascular Outcomes.
    J Am Coll Cardiol. 2018;71:279-288.
    >> Share

  119. KLEINBONGARD P, Peters J, Jakob H, Heusch G, et al
    Persistent Survival Benefit From Remote Ischemic Pre-Conditioning in Patients Undergoing Coronary Artery Bypass Surgery.
    J Am Coll Cardiol. 2018;71:252-254.
    >> Share

  120. TSIMIKAS S, Fazio S, Ferdinand KC, Ginsberg HN, et al
    NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis.
    J Am Coll Cardiol. 2018;71:177-192.
    >> Share

  121. GIBSON CM, Nafee T, Kerneis M
    Silent Myocardial Infarction: Listen to the Evidence.
    J Am Coll Cardiol. 2018;71:9-11.
    >> Share

  122. MAGNUSON EA, Bonaca MP, Bhatt DL, Cohen M, et al
    Reply: Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Analysis by Subgroups.
    J Am Coll Cardiol. 2018;71:108.
    >> Share

  123. LOZANO I, Rondan J, Vegas JM, Segovia E, et al
    Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Analysis by Subgroups.
    J Am Coll Cardiol. 2018;71:107-108.
    >> Share

  124. QURESHI WT, Zhang ZM, Chang PP, Rosamond WD, et al
    Silent Myocardial Infarction and Long-Term Risk of Heart Failure: The ARIC Study.
    J Am Coll Cardiol. 2018;71:1-8.
    >> Share

  125. DICKERT NW, Miller FG
    Sham-Controlled Trials for Coronary Interventions: Ethically Acceptable and Ethically Important.
    J Am Coll Cardiol. 2018;71:95-97.
    >> Share

  126. BRENNAN JM
    Reply: Transcatheter Versus Surgical Aortic Valve Replacement: Unneglectable Concomitant Coronary Artery Disease.
    J Am Coll Cardiol. 2018;71:106-107.
    >> Share

  127. HU K, Chen J, Wan Y, Wang C, et al
    Transcatheter Versus Surgical Aortic Valve Replacement: Unneglectable Concomitant Coronary Artery Disease.
    J Am Coll Cardiol. 2018;71:105-106.
    >> Share

    December 2017
  128. LOGSTRUP BB, Ellingsen T, Pedersen AB, Kjaersgaard A, et al
    Heart Failure and Ischemic Heart Disease in Patients With Rheumatoid Arthritis.
    J Am Coll Cardiol. 2017;70:3069-3071.
    >> Share

  129. RAMANATHAN K, Abel JG, Park JE, Fung A, et al
    Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary Syndromes.
    J Am Coll Cardiol. 2017;70:2995-3006.
    >> Share

  130. STEWART WJ
    Atrial Myocardial Infarction: A Neglected Stalker in Coronary Patients.
    J Am Coll Cardiol. 2017;70:2890-2892.
    >> Share

  131. AGUERO J, Galan-Arriola C, Fernandez-Jimenez R, Sanchez-Gonzalez J, et al
    Atrial Infarction and Ischemic Mitral Regurgitation Contribute to Post-MI Remodeling of the Left Atrium.
    J Am Coll Cardiol. 2017;70:2878-2889.
    >> Share

  132. STONE GW, Abizaid A, Onuma Y, Seth A, et al
    Effect of Technique on Outcomes Following Bioresorbable Vascular Scaffold Implantation: Analysis From the ABSORB Trials.
    J Am Coll Cardiol. 2017;70:2863-2874.
    >> Share

  133. KEREIAKES DJ, Ellis SG, Metzger C, Caputo RP, et al
    3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial.
    J Am Coll Cardiol. 2017;70:2852-2862.
    >> Share

  134. OSBORNE MT, Bajaj NS, Taqueti VR, Gupta A, et al
    Coronary Microvascular Dysfunction Identifies Patients at High Risk of Adverse Events Across Cardiometabolic Diseases.
    J Am Coll Cardiol. 2017;70:2835-2837.
    >> Share

  135. ZANNAD F, Alonso Garcia MLA, Borer JS, Stough WG, et al
    Role of Payers in the Development of Cardiovascular Therapeutics: Misalignment Between Approval and Reimbursement.
    J Am Coll Cardiol. 2017;70:2822-2830.
    >> Share

  136. MUSUNURU K
    Genome Editing: The Recent History and Perspective in Cardiovascular Diseases.
    J Am Coll Cardiol. 2017;70:2808-2821.
    >> Share

  137. YU L, Zhou L, Cao G, Po SS, et al
    Optogenetic Modulation of Cardiac Sympathetic Nerve Activity to Prevent Ventricular Arrhythmias.
    J Am Coll Cardiol. 2017;70:2778-2790.
    >> Share

    November 2017
  138. CHEN SL, Zhang JJ, Han Y, Kan J, et al
    Double Kissing Crush Versus Provisional Stenting for Left Main Distal Bifurcation Lesions: DKCRUSH-V Randomized Trial.
    J Am Coll Cardiol. 2017;70:2605-2617.
    >> Share

  139. FUSTER V, Frazer J, Snair M, Vedanthan R, et al
    The Future Role of the United States in Global Health: Emphasis on Cardiovascular Disease.
    J Am Coll Cardiol. 2017 Nov 23. pii: S0735-1097(17)41525.
    >> Share

  140. CHANG HM, Okwuosa TM, Scarabelli T, Moudgil R, et al
    Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2.
    J Am Coll Cardiol. 2017;70:2552-2565.
    >> Share

  141. CHANG HM, Moudgil R, Scarabelli T, Okwuosa TM, et al
    Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1.
    J Am Coll Cardiol. 2017;70:2536-2551.
    >> Share

  142. GUASCH-FERRE M, Liu X, Malik VS, Sun Q, et al
    Nut Consumption and Risk of Cardiovascular Disease.
    J Am Coll Cardiol. 2017;70:2519-2532.
    >> Share

  143. BLUMENTHAL RS, Ambinder DI, McEvoy JW
    Cardiovascular Health, Simplified.
    J Am Coll Cardiol. 2017;70:2474-2475.
    >> Share

  144. FERNANDEZ-ALVIRA JM, Fuster V, Pocock S, Sanz J, et al
    Predicting Subclinical Atherosclerosis in Low-Risk Individuals: Ideal Cardiovascular Health Score and Fuster-BEWAT Score.
    J Am Coll Cardiol. 2017;70:2463-2473.
    >> Share

  145. NATSUMEDA M, Florea V, Rieger AC, Tompkins BA, et al
    A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration.
    J Am Coll Cardiol. 2017;70:2504-2515.
    >> Share

  146. MOTOVSKA Z, Hlinomaz O, Kala P, Hromadka M, et al
    One-year Outcomes of Prasugrel Versus Ticagrelor In Acute Myocardial Infarction Treated With Primary Angioplasty: The PRAGUE-18 Study.
    J Am Coll Cardiol. 2017 Nov 9. pii: S0735-1097(17)41524.
    >> Share

  147. SINGH A, Collins BL, Gupta A, Fatima A, et al
    Cardiovascular Risk and Statin Eligibility of Young Adults After an Myocardial Infarction: Partners YOUNG-MI Registry.
    J Am Coll Cardiol. 2017 Nov 8. pii: S0735-1097(17)41522.
    >> Share

  148. SAIA F, Palazzini M, Taglieri N, Manes A, et al
    Reply: Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization.
    J Am Coll Cardiol. 2017;70:2460-2461.
    >> Share

  149. MONTERO CABEZAS JM, Nuche Berenguer J, Velazquez Martin MT, Escribano Subias P, et al
    Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization.
    J Am Coll Cardiol. 2017;70:2459-2460.
    >> Share

  150. DIVAKARAN S, Loscalzo J
    The Role of Nitroglycerin and Other Nitrogen Oxides in Cardiovascular Therapeutics.
    J Am Coll Cardiol. 2017;70:2393-2410.
    >> Share

  151. AZIZ A, Hansen HS, Sechtem U, Prescott E, et al
    Sex-Related Differences in Vasomotor Function in Patients With Angina and Unobstructed Coronary Arteries.
    J Am Coll Cardiol. 2017;70:2349-2358.
    >> Share

  152. YAMAJI K, Ueki Y, Souteyrand G, Daemen J, et al
    Mechanisms of Very Late Bioresorbable Scaffold Thrombosis: The INVEST Registry.
    J Am Coll Cardiol. 2017;70:2330-2344.
    >> Share

    October 2017
  153. TWEET MS, Codsi E, Best PJM, Gulati R, et al
    Menstrual Chest Pain in Women With History of Spontaneous Coronary Artery Dissection.
    J Am Coll Cardiol. 2017;70:2308-2309.
    >> Share

  154. YEH RW, Kereiakes DJ, Steg PG, Cutlip DE, et al
    Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2017;70:2213-2223.
    >> Share

  155. MARK DB, Patel MR
    Patient-Reported Outcomes in Revascularization Decisions for Left Main Disease: Sharing the EXCELlence.
    J Am Coll Cardiol. 2017 Oct 25. pii: S0735-1097(17)41356.
    >> Share

  156. PALMERINI T, Biondi-Zoccai G, Stone GW
    Reply: The Optimal Duration of Dual-Antiplatelet Therapy After Coronary Stenting: Shorter or Longer?
    J Am Coll Cardiol. 2017;70:2210-2211.
    >> Share

  157. GUO WQ, Li L, Su Q
    The Optimal Duration of Dual-Antiplatelet Therapy After Coronary Stenting: Shorter or Longer?
    J Am Coll Cardiol. 2017;70:2208-2210.
    >> Share

  158. WADHERA RK
    Cardiovascular Medicine Amid Evolving Health Policy: Time to Train a Generation of Policy Leaders.
    J Am Coll Cardiol. 2017;70:2201-2204.
    >> Share

  159. LEE JM, Park J, Hwang D, Kim CH, et al
    Similarity and Difference of Resting Distal to Aortic Coronary Pressure and Instantaneous Wave-Free Ratio.
    J Am Coll Cardiol. 2017;70:2114-2123.
    >> Share

  160. XU B, Tu S, Qiao S, Qu X, et al
    Angiography-Based Quantitative Flow Ratio for Online Assessment of Coronary Stenosis: FAVOR II China Study.
    J Am Coll Cardiol. 2017 Oct 20. pii: S0735-1097(17)41278.
    >> Share

  161. BARON SJ, Chinnakondepalli K, Magnuson EA, Kandzari DE, et al
    Quality of Life after Everolimus-Eluting Stents or Bypass Surgery for Treatment of Left Main Disease.
    J Am Coll Cardiol. 2017 Oct 20. pii: S0735-1097(17)41279.
    >> Share

  162. ALEXOPOULOS D, Despotopoulos S, Xanthopoulou I, Davlouros P, et al
    Low-Dose Ticagrelor Versus Clopidogrel in Patients With Prior Myocardial Infarction.
    J Am Coll Cardiol. 2017;70:2091-2092.
    >> Share

  163. GOROG DA, Fayad ZA, Fuster V
    Arterial Thrombus Stability: Does It Matter and Can We Detect It?
    J Am Coll Cardiol. 2017;70:2036-2047.
    >> Share

  164. DAI Y, Shen Y, Li QR, Ding FH, et al
    Glycated Apolipoprotein A-IV Induces Atherogenesis in Patients With CAD in Type 2 Diabetes.
    J Am Coll Cardiol. 2017;70:2006-2019.
    >> Share

  165. DOMINGUEZ H, Sanchez-Ferrer CF
    The Role of Glycated Proteins on Cardiovascular Diabetic Complications: New Findings.
    J Am Coll Cardiol. 2017;70:2020-2021.
    >> Share

  166. BONOW RO, Brown AS, Gillam LD, Kapadia SR, et al
    ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Tho
    J Am Coll Cardiol. 2017 Oct 16. pii: S0735-1097(17)39676.
    >> Share

  167. ROVIO SP, Raitakari OT
    Reply: Cardiovascular Risk Factors From Childhood and Midlife Cognitive Performance.
    J Am Coll Cardiol. 2017;70:1946-1947.
    >> Share

  168. WALDMANN V, Gaye B
    Cardiovascular Risk Factors From Childhood and Midlife Cognitive Performance.
    J Am Coll Cardiol. 2017;70:1945-1946.
    >> Share

  169. SHAH R, Murthy VL, Colangelo LA, Reis JP, et al
    Submaximal Blood Pressure Responses to Exercise in Young Adulthood and Long-Term Cardiovascular Health.
    J Am Coll Cardiol. 2017;70:1941-1943.
    >> Share

  170. ALYESH D, Petrilli C, Obi A
    Innovating Toward High-Value Cardiovascular Care.
    J Am Coll Cardiol. 2017;70:1935-1939.
    >> Share

  171. BAGGISH AL, Battle RW, Beckerman JG, Bove AA, et al
    Sports Cardiology: Core Curriculum for Providing Cardiovascular Care to Competitive Athletes and Highly Active People.
    J Am Coll Cardiol. 2017;70:1902-1918.
    >> Share

  172. GIUSTINO G, Mehran R, Dangas GD, Kirtane AJ, et al
    Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI.
    J Am Coll Cardiol. 2017;70:1846-1857.
    >> Share

  173. EIJSVOGELS TMH, Maessen MFH
    Exercise for Coronary Heart Disease Patients: Little Is Good, More Is Better, Vigorous Is Best.
    J Am Coll Cardiol. 2017;70:1701-1703.
    >> Share

  174. STEWART RAH, Held C, Hadziosmanovic N, Armstrong PW, et al
    Physical Activity and Mortality in Patients With Stable Coronary Heart Disease.
    J Am Coll Cardiol. 2017;70:1689-1700.
    >> Share

  175. PATRONO C, Morais J, Baigent C, Collet JP, et al
    Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis.
    J Am Coll Cardiol. 2017;70:1760-1776.
    >> Share

  176. AMOR-SALAMANCA A, Castillo S, Gonzalez-Vioque E, Dominguez F, et al
    Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
    J Am Coll Cardiol. 2017;70:1732-1740.
    >> Share

    September 2017
  177. EL-BATTRAWY I, Borggrefe M, Akin I
    beta-Blockers and Outcome After Acute Myocardial Infarction.
    J Am Coll Cardiol. 2017;70:1685.
    >> Share

  178. LI JG, Xu H
    Should Beta-Blockers Be Routinely Prescribed for Myocardial Infarction Without Heart Failure or Ventricular Dysfunction?
    J Am Coll Cardiol. 2017;70:1685-1686.
    >> Share

  179. JANUZZI JL, Sandoval Y
    The Many Faces of Type 2 Myocardial Infarction.
    J Am Coll Cardiol. 2017;70:1569-1572.
    >> Share

  180. NESTELBERGER T, Boeddinghaus J, Badertscher P, Twerenbold R, et al
    Effect of Definition on Incidence and Prognosis of Type 2 Myocardial Infarction.
    J Am Coll Cardiol. 2017;70:1558-1568.
    >> Share

  181. KORHONEN MJ, Robinson JG, Annis IE, Hickson RP, et al
    Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.
    J Am Coll Cardiol. 2017;70:1543-1554.
    >> Share

  182. DAMP JB, Mendes LA, Goldman M, Stern EH, et al
    ABIM/ACC Competency-Based Education Pilot in Internal Medicine and Cardiovascular Disease.
    J Am Coll Cardiol. 2017;70:1534-1535.
    >> Share

  183. GURBEL PA, Navarese EP, Tantry US
    Exploration of PCSK9 as a Cardiovascular Risk Factor: Is There a Link to the Platelet?
    J Am Coll Cardiol. 2017;70:1463-1466.
    >> Share

  184. PASTORI D, Nocella C, Farcomeni A, Bartimoccia S, et al
    Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1455-1462.
    >> Share

  185. BEA JW, Sweitzer NK
    More Appropriate Cardiovascular Risk Screening Through Understanding Complex Phenotypes: Mind the Gap.
    J Am Coll Cardiol. 2017;70:1438-1440.
    >> Share

  186. CALEYACHETTY R, Thomas GN, Toulis KA, Mohammed N, et al
    Metabolically Healthy Obese and Incident Cardiovascular Disease Events Among 3.5 Million Men and Women.
    J Am Coll Cardiol. 2017;70:1429-1437.
    >> Share

  187. TANIMOTO T, Parseghian MH, Nakahara T, Kawai H, et al
    Cardioprotective Effects of HSP72 Administration on Ischemia-Reperfusion Injury.
    J Am Coll Cardiol. 2017;70:1479-1492.
    >> Share

  188. JNEID H, Addison D, Bhatt DL, Fonarow GC, et al
    2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
    J Am Coll Cardiol. 2017 Sep 14. pii: S0735-1097(17)37855.
    >> Share

  189. SIVAGNANAM K, Mendes LA, Schlendorf KH, Damp JB, et al
    Bridge to Transplantation: Advanced Heart Failure and Transplant Cardiology Training for Cardiovascular Disease Fellows.
    J Am Coll Cardiol. 2017;70:1413-1416.
    >> Share

  190. BITTL JA, Maron DJ
    Using Absolute Event Rates to See What Works in Cardiovascular Medicine.
    J Am Coll Cardiol. 2017;70:1376-1378.
    >> Share

  191. KING JB, Azadani PN, Suksaranjit P, Bress AP, et al
    Left Atrial Fibrosis and Risk of Cerebrovascular and Cardiovascular Events in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1311-1321.
    >> Share

  192. GOTBERG M, Cook CM, Sen S, Nijjer S, et al
    The Evolving Future of Instantaneous Wave-Free Ratio and Fractional Flow Reserve.
    J Am Coll Cardiol. 2017;70:1379-1402.
    >> Share

  193. BONACA MP, Storey RF, Theroux P, Steg PG, et al
    Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54.
    J Am Coll Cardiol. 2017;70:1368-1375.
    >> Share

  194. BARTKO PE, Dal-Bianco JP, Guerrero JL, Beaudoin J, et al
    Effect of Losartan on Mitral Valve Changes After Myocardial Infarction.
    J Am Coll Cardiol. 2017;70:1232-1244.
    >> Share

  195. WARRAICH HJ, Hernandez AF, Allen LA
    How Medicine Has Changed the End of Life for Patients With Cardiovascular Disease.
    J Am Coll Cardiol. 2017;70:1276-1289.
    >> Share

  196. PEPINE CJ, Park K
    Fertility Therapy and Long-Term Cardiovascular Risk: Raising More Questions Than Answers?
    J Am Coll Cardiol. 2017;70:1214-1215.
    >> Share

  197. DAYAN N, Filion KB, Okano M, Kilmartin C, et al
    Cardiovascular Risk Following Fertility Therapy: Systematic Review and Meta-Analysis.
    J Am Coll Cardiol. 2017;70:1203-1213.
    >> Share

    August 2017
  198. LLOYD-JONES DM, Morris PB, Ballantyne CM, Birtcher KK, et al
    2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Tas
    J Am Coll Cardiol. 2017 Aug 30. pii: S0735-1097(17)38898.
    >> Share

  199. SAW J, Humphries K, Aymong E, Sedlak T, et al
    Spontaneous Coronary Artery Dissection: Clinical Outcomes and Risk of Recurrence.
    J Am Coll Cardiol. 2017;70:1148-1158.
    >> Share

  200. YANNOPOULOS D, Bartos JA, Raveendran G, Conterato M, et al
    Coronary Artery Disease in Patients With Out-of-Hospital Refractory Ventricular Fibrillation Cardiac Arrest.
    J Am Coll Cardiol. 2017;70:1109-1117.
    >> Share

  201. SECEMSKY EA, Gallagher R, Harkness J, Pomerantsev E, et al
    Target Vessel Revascularization and Territory of Myocardial Ischemia in Patients With Chronic Total Occlusions.
    J Am Coll Cardiol. 2017;70:1196-1197.
    >> Share

  202. TWEET MS, Olin JW
    Insights Into Spontaneous Coronary Artery Dissection: Can Recurrence Be Prevented?
    J Am Coll Cardiol. 2017;70:1159-1161.
    >> Share

  203. DOHERTY JU, Kort S, Mehran R, Schoenhagen P, et al
    ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for Multimodality Imaging in Valvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surge
    J Am Coll Cardiol. 2017 Aug 25. pii: S0735-1097(17)38870.
    >> Share

  204. NYSTROM T, Sartipy U, Franzen S, Eliasson B, et al
    PCI Versus CABG in Patients With Type 1 Diabetes and Multivessel Disease.
    J Am Coll Cardiol. 2017 Aug 23. pii: S0735-1097(17)38889.
    >> Share

  205. TWERENBOLD R, Boeddinghaus J, Nestelberger T, Wildi K, et al
    Clinical Use of High-Sensitivity Cardiac Troponin in Patients With Suspected Myocardial Infarction.
    J Am Coll Cardiol. 2017;70:996-1012.
    >> Share

  206. TRAVERS JG, Kamal FA, Valiente-Alandi I, Nieman ML, et al
    Pharmacological and Activated Fibroblast Targeting of Gbetagamma-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression.
    J Am Coll Cardiol. 2017;70:958-971.
    >> Share

  207. KHOT UN, Johnson MJ, Lowry AM, Rajeswaran J, et al
    The Time-Varying Risk of Cardiovascular and Noncardiovascular Readmissions Early After Acute Myocardial Infarction.
    J Am Coll Cardiol. 2017;70:1101-1103.
    >> Share

  208. XI B, Veeranki SP, Zhao M, Ma C, et al
    Relationship of Alcohol Consumption to All-Cause, Cardiovascular, and Cancer-Related Mortality in U.S. Adults.
    J Am Coll Cardiol. 2017;70:913-922.
    >> Share

  209. YAN AT, Koh M, Ko DT
    Reply: Coronary Artery Disease Affects Symptomatology of Aortic Valve Stenosis.
    J Am Coll Cardiol. 2017;70:1104.
    >> Share

  210. BOEKHOLDT SM, Arsenault BJ, Mathieu P
    Coronary Artery Disease Affects Symptomatology of Aortic Valve Stenosis.
    J Am Coll Cardiol. 2017;70:1103-1104.
    >> Share

  211. DOMANSKI MJ, Farkouh ME
    Type 1 Diabetes, Coronary Disease Complexity, and Optimal Revascularization Strategy.
    J Am Coll Cardiol. 2017 Aug 21. pii: S0735-1097(17)39143.
    >> Share

  212. OMLAND T, Kullo IJ
    Biomarker-Based Risk Models to Risk Stratify Patients With Stable Coronary Heart Disease.
    J Am Coll Cardiol. 2017;70:827-829.
    >> Share

  213. LINDHOLM D, Lindback J, Armstrong PW, Budaj A, et al
    Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease.
    J Am Coll Cardiol. 2017;70:813-826.
    >> Share

  214. SHAH AD, Denaxas S, Nicholas O, Hingorani AD, et al
    Reply: Neutrophil Count Is Associated With Risks of Cardiovascular Diseases.
    J Am Coll Cardiol. 2017;70:912.
    >> Share

  215. LI D, Yu J, Zeng R, Zhao L, et al
    Neutrophil Count Is Associated With Risks of Cardiovascular Diseases.
    J Am Coll Cardiol. 2017;70:911-912.
    >> Share

  216. LV J, Qi L, Li L
    Reply: Low-Risk Lifestyle Is a Strong Predictor of Outcomes Across Populations With Different Cardiovascular Health Manifestations.
    J Am Coll Cardiol. 2017;70:910-911.
    >> Share

  217. GAYE B, Djousse L, Empana JP
    Low-Risk Lifestyle Is a Strong Predictor of Outcomes Across Populations With Different Cardiovascular Health Manifestations.
    J Am Coll Cardiol. 2017;70:910.
    >> Share

  218. NEWMAN JD, Schwartzbard AZ, Weintraub HS, Goldberg IJ, et al
    Primary Prevention of Cardiovascular Disease in Diabetes Mellitus.
    J Am Coll Cardiol. 2017;70:883-893.
    >> Share

  219. MACAYA F, Ryan N, Salinas P, Pocock SJ, et al
    Challenges in the Design and Interpretation of Noninferiority Trials: Insights From Recent Stent Trials.
    J Am Coll Cardiol. 2017;70:894-903.
    >> Share

  220. KATO S, Saito N, Nakachi T, Fukui K, et al
    Stress Perfusion Coronary Flow Reserve Versus Cardiac Magnetic Resonance for Known or Suspected CAD.
    J Am Coll Cardiol. 2017;70:869-879.
    >> Share

  221. DHUTIA H, Malhotra A, Finocchiaro G, Merghani A, et al
    Impact of the International Recommendations for Electrocardiographic Interpretation on Cardiovascular Screening in Young Athletes.
    J Am Coll Cardiol. 2017;70:805-807.
    >> Share

  222. YANIZ-GALENDE E, Roux M, Nadaud S, Mougenot N, et al
    Fibrogenic Potential of PW1/Peg3 Expressing Cardiac Stem Cells.
    J Am Coll Cardiol. 2017;70:728-741.
    >> Share

  223. SERBAN MC, Muntner P, Rosenson RS
    Reply: Statin Intolerance and Risk for Recurrent Myocardial Infarction, Coronary Heart Disease Events, and All-Cause Mortality.
    J Am Coll Cardiol. 2017;70:685-686.
    >> Share

  224. MASCITELLI L, Goldstein MR
    Statin Intolerance and the Obsession With Aggressive Cholesterol Lowering to Prevent Coronary Heart Disease.
    J Am Coll Cardiol. 2017;70:684.
    >> Share

  225. NAVARESE EP, Tijssen JGP
    Striking the Balance Between Benefits and Costs of Ticagrelor Beyond 1 Year After Myocardial Infarction.
    J Am Coll Cardiol. 2017;70:539-541.
    >> Share

  226. MAGNUSON EA, Li H, Wang K, Vilain K, et al
    Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 Trial.
    J Am Coll Cardiol. 2017;70:527-538.
    >> Share

  227. ADUSUMALLI S, Fiorilli PN, Saybolt MD
    Educating the MACRA-Ready Cardiologist: Developing Competencies in Value-Based Cardiovascular Medicine.
    J Am Coll Cardiol. 2017;70:680-683.
    >> Share

  228. VAN DER HARST P, de Windt LJ, Chambers JC
    Translational Perspective on Epigenetics in Cardiovascular Disease.
    J Am Coll Cardiol. 2017;70:590-606.
    >> Share

  229. WILLEIT P, Welsh P, Evans JDW, Tschiderer L, et al
    High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants.
    J Am Coll Cardiol. 2017;70:558-568.
    >> Share

  230. RAZA S, Blackstone EH, Houghtaling PL, Rajeswaran J, et al
    Influence of Diabetes on Long-Term Coronary Artery Bypass Graft Patency.
    J Am Coll Cardiol. 2017;70:515-524.
    >> Share

  231. COLOMBO A, Giannini F, Briguori C
    Should We Still Have Bare-Metal Stents Available in Our Catheterization Laboratory?
    J Am Coll Cardiol. 2017;70:607-619.
    >> Share

    July 2017
  232. SATIJA A, Bhupathiraju SN, Spiegelman D, Chiuve SE, et al
    Healthful and Unhealthful Plant-Based Diets and the Risk of Coronary Heart Disease in U.S. Adults.
    J Am Coll Cardiol. 2017;70:411-422.
    >> Share

  233. SAID MA, Eppinga RN, Hagemeijer Y, Verweij N, et al
    Telomere Length and Risk of Cardiovascular Disease and Cancer.
    J Am Coll Cardiol. 2017;70:506-507.
    >> Share

  234. GORNIK HL
    Spontaneous Coronary Artery Dissection: The Zebra Has Been Spotted: Now Let's Study its Stripes.
    J Am Coll Cardiol. 2017;70:436-438.
    >> Share

  235. TWEET MS, Hayes SN, Codsi E, Gulati R, et al
    Spontaneous Coronary Artery Dissection Associated With Pregnancy.
    J Am Coll Cardiol. 2017;70:426-435.
    >> Share

  236. SHAW LJ, Pepine CJ, Xie J, Mehta PK, et al
    Quality and Equitable Health Care Gaps for Women: Attributions to Sex Differences in Cardiovascular Medicine.
    J Am Coll Cardiol. 2017;70:373-388.
    >> Share

  237. MINNEBOO M, Lachman S, Snaterse M, Jorstad HT, et al
    Community-Based Lifestyle Intervention in Patients With Coronary Artery Disease: The RESPONSE-2 Trial.
    J Am Coll Cardiol. 2017;70:318-327.
    >> Share

  238. KIM MC, Yun SC, Lee HB, Lee PH, et al
    Herpes Zoster Increases the Risk of Stroke and Myocardial Infarction.
    J Am Coll Cardiol. 2017;70:295-296.
    >> Share

  239. LIN J, DeLuca JR, Lu MT, Ruehm SG, et al
    Extreme Endurance Exercise and Progressive Coronary Artery Disease.
    J Am Coll Cardiol. 2017;70:293-295.
    >> Share

  240. NIEMANN B, Rohrbach S, Miller MR, Newby DE, et al
    Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution: Part 3 of a 3-Part Series.
    J Am Coll Cardiol. 2017;70:230-251.
    >> Share

  241. SACK MN, Fyhrquist FY, Saijonmaa OJ, Fuster V, et al
    Basic Biology of Oxidative Stress and the Cardiovascular System: Part 1 of a 3-Part Series.
    J Am Coll Cardiol. 2017;70:196-211.
    >> Share

  242. HEINECKE JW, Bornfeldt KE
    A Long Road Ahead for Discovering New HDL Metrics That Reflect Cardiovascular Disease Risk.
    J Am Coll Cardiol. 2017;70:179-181.
    >> Share

  243. CANNAVO A, Rengo G, Liccardo D, Pun A, et al
    beta1-Blockade Prevents Post-Ischemic Myocardial Decompensation Via beta3AR-Dependent Protective Sphingosine-1 Phosphate Signaling.
    J Am Coll Cardiol. 2017;70:182-192.
    >> Share

  244. PADRO T, Cubedo J, Camino S, Bejar MT, et al
    Detrimental Effect of Hypercholesterolemia on High-Density Lipoprotein Particle Remodeling in Pigs.
    J Am Coll Cardiol. 2017;70:165-178.
    >> Share

  245. AL MHEID I, Quyyumi AA
    Vitamin D and Cardiovascular Disease: Controversy Unresolved.
    J Am Coll Cardiol. 2017;70:89-100.
    >> Share

  246. SHARMA S, Rozen G, Duran J, Mela T, et al
    Sudden Cardiac Death in Patients With Spontaneous Coronary Artery Dissection.
    J Am Coll Cardiol. 2017;70:114-115.
    >> Share

  247. HAVAKUK O, Rezkalla SH, Kloner RA
    The Cardiovascular Effects of Cocaine.
    J Am Coll Cardiol. 2017;70:101-113.
    >> Share

  248. SERRUYS PW, Katagiri Y, Sotomi Y, Zeng Y, et al
    Arterial Remodeling After Bioresorbable Scaffolds and Metallic Stents.
    J Am Coll Cardiol. 2017;70:60-74.
    >> Share

    June 2017
  249. GAYE B, Canonico M, Perier MC, Samieri C, et al
    Ideal Cardiovascular Health, Mortality, and Vascular Events in Elderly Subjects: The Three-City Study.
    J Am Coll Cardiol. 2017;69:3015-3026.
    >> Share

  250. SORRENTINO S, Giustino G, Mehran R, Kini AS, et al
    Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents.
    J Am Coll Cardiol. 2017;69:3055-3066.
    >> Share

  251. HALPERIN JL
    Preventing Myocardial Infarction in Patients With Atrial Fibrillation: Another Piece of the Puzzle.
    J Am Coll Cardiol. 2017;69:2910-2912.
    >> Share

  252. LEE CJ, Pallisgaard JL, Olesen JB, Carlson N, et al
    Antithrombotic Therapy and First Myocardial Infarction in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2901-2909.
    >> Share

  253. IANNOPOLLO G, Ferlini M, Kozinski M, Ormezzano MF, et al
    Patient Outcomes With STEMI Caused by Aneurysmal Coronary Artery Disease and Treated With Primary PCI.
    J Am Coll Cardiol. 2017;69:3006-3007.
    >> Share

  254. WANG EA, Redmond N, Dennison Himmelfarb CR, Pettit B, et al
    Cardiovascular Disease in Incarcerated Populations.
    J Am Coll Cardiol. 2017;69:2967-2976.
    >> Share

  255. HAO P, Jiang F, Cheng J, Ma L, et al
    Traditional Chinese Medicine for Cardiovascular Disease: Evidence and Potential Mechanisms.
    J Am Coll Cardiol. 2017;69:2952-2966.
    >> Share

  256. BAIREY MERZ CN, Andersen H, Sprague E, Burns A, et al
    Knowledge, Attitudes, and Beliefs Regarding Cardiovascular Disease in Women: The Women's Heart Alliance.
    J Am Coll Cardiol. 2017 Jun 20. pii: S0735-1097(17)37407.
    >> Share

  257. FANAROFF AC, Zakroysky P, Dai D, Wojdyla D, et al
    Outcomes of PCI in Relation to Procedural Characteristics and Operator Volumes in the United States.
    J Am Coll Cardiol. 2017;69:2913-2924.
    >> Share

  258. HUANG Y, Huang W, Hu Y
    Is White-Coat Hypertension Associated With Risk of Cardiovascular Diseases?
    J Am Coll Cardiol. 2017;69:2880.
    >> Share

  259. FRANKLIN SS, Thijs L, Staessen JA
    Reply: Is White-Coat Hypertension Associated With Risk of Cardiovascular Diseases?
    J Am Coll Cardiol. 2017;69:2880-2881.
    >> Share

  260. INDIK JH, Duhigg LM, McDonald FS, Lipner RS, et al
    Performance on the Cardiovascular In-Training Examination in Relation to the ABIM Cardiovascular Disease Certification Examination.
    J Am Coll Cardiol. 2017;69:2862-2868.
    >> Share

  261. ALFONSO F, Rivero F
    Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension.
    J Am Coll Cardiol. 2017;69:2818-2820.
    >> Share

  262. GALIE N, Saia F, Palazzini M, Manes A, et al
    Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina.
    J Am Coll Cardiol. 2017;69:2808-2817.
    >> Share

  263. LONBORG J, Engstrom T, Ahtarovski KA, Nepper-Christensen L, et al
    Myocardial Damage in Patients With Deferred Stenting After STEMI: A DANAMI-3-DEFER Substudy.
    J Am Coll Cardiol. 2017;69:2794-2804.
    >> Share

  264. JANUZZI JL JR, Butler J, Jarolim P, Sattar N, et al
    Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes.
    J Am Coll Cardiol. 2017 Jun 9. pii: S0735-1097(17)37754.
    >> Share

  265. SHAFIQ A, Goyal A, Jones PG, Sahil S, et al
    Serum Magnesium Levels and In-Hospital Mortality in Acute Myocardial Infarction.
    J Am Coll Cardiol. 2017;69:2771-2772.
    >> Share

  266. DONDO TB, Hall M, West RM, Jernberg T, et al
    beta-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction.
    J Am Coll Cardiol. 2017;69:2710-2720.
    >> Share

  267. ROSENSON RS, Farkouh ME, Mefford M, Bittner V, et al
    Trends in Use of High-Intensity Statin Therapy After Myocardial Infarction, 2011 to 2014.
    J Am Coll Cardiol. 2017;69:2696-2706.
    >> Share

  268. WANG J, Liu J, Guo W, Bai Y, et al
    Multiple Biomarkers in the Context of Conventional Risk Factors in Patients With Coronary Artery Disease.
    J Am Coll Cardiol. 2017;69:2769-2770.
    >> Share

  269. POTHINENI NVK, Karathanasis SK, Ding Z, Arulandu A, et al
    LOX-1 in Atherosclerosis and Myocardial Ischemia: Biology, Genetics, and Modulation.
    J Am Coll Cardiol. 2017;69:2759-2768.
    >> Share

  270. JEREMIAS A, Kirtane AJ, Stone GW
    A Test in Context: Fractional Flow Reserve: Accuracy, Prognostic Implications, and Limitations.
    J Am Coll Cardiol. 2017;69:2748-2758.
    >> Share

    May 2017
  271. OUELLETTE ML, Beller GA, Loffler AI, Workman VK, et al
    Appropriate Referrals of Angiography Despite High Prevalence of Normal Coronary Arteries or Nonobstructive CAD.
    J Am Coll Cardiol. 2017;69:2673-2675.
    >> Share

  272. KRITTANAWONG C, Zhang H, Wang Z, Aydar M, et al
    Artificial Intelligence in Precision Cardiovascular Medicine.
    J Am Coll Cardiol. 2017;69:2657-2664.
    >> Share

  273. SATTAR N, Petrie MC, Zinman B, Januzzi JL Jr, et al
    Novel Diabetes Drugs and the Cardiovascular Specialist.
    J Am Coll Cardiol. 2017;69:2646-2656.
    >> Share

  274. NEJATIAN A, Omstedt A, Hoijer J, Hansson LO, et al
    Outcomes in Patients With Chest Pain Discharged After Evaluation Using a High-Sensitivity Troponin T Assay.
    J Am Coll Cardiol. 2017;69:2622-2630.
    >> Share

  275. ELZE MC, Gregson J, Baber U, Williamson E, et al
    Reply: Last Nail in the Coffin for Propensity Scores in Observational Cardiovascular Studies?
    J Am Coll Cardiol. 2017;69:2576-2577.
    >> Share

  276. BIONDI-ZOCCAI G, Marullo AGM, Peruzzi M, Palmerini T, et al
    Last Nail in the Coffin for Propensity Scores in Observational Cardiovascular Studies?
    J Am Coll Cardiol. 2017;69:2575-2576.
    >> Share

  277. XING L, Higuma T, Wang Z, Aguirre AD, et al
    Clinical Significance of Lipid-Rich Plaque Detected by Optical Coherence Tomography: A 4-Year Follow-Up Study.
    J Am Coll Cardiol. 2017;69:2502-2513.
    >> Share

  278. BOKMA JP, Winter MM, Kuijpers JM, Jongbloed MR, et al
    Role of Acquired Cardiovascular Disease in Tetralogy of Fallot Patients >50 Years of Age.
    J Am Coll Cardiol. 2017;69:2465-2466.
    >> Share

  279. ALBAGHDADI M
    Global Cardiovascular Health: A Role for the Interventionalist.
    J Am Coll Cardiol. 2017;69:2461-2464.
    >> Share

  280. MUNZEL T, Heusch G
    Chest Pain Unit Network in Germany: Its Effect on Patients With Acute Coronary Syndromes.
    J Am Coll Cardiol. 2017;69:2459-2460.
    >> Share

  281. MUNTNER P, Whelton PK
    Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment.
    J Am Coll Cardiol. 2017;69:2446-2456.
    >> Share

  282. ROTH GA, Johnson C, Abajobir A, Abd-Allah F, et al
    Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015.
    J Am Coll Cardiol. 2017 May 15. pii: S0735-1097(17)37244.
    >> Share

  283. ANDO G, Cortese B, Russo F, Rothenbuhler M, et al
    Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX.
    J Am Coll Cardiol. 2017 May 11. pii: S0735-1097(17)36897.
    >> Share

  284. MOZAFFARIAN D
    Scourge of Global Cardiovascular Disease: Time for Health Care Systems Reform and Precision Population Health.
    J Am Coll Cardiol. 2017 May 10. pii: S0735-1097(17)37316.
    >> Share

  285. ELIAS J, Hoebers LP, van Dongen IM, Claessen BEPM, et al
    Impact of Chronic Total Occlusion Location on LV Function in ST-Segment Elevation Myocardial Infarction Patients.
    J Am Coll Cardiol. 2017;69:2347-2348.
    >> Share

  286. STONE PH
    Ranolazine in Diabetics With Stable Ischemic Heart Disease: Greatest Efficacy Related to Greatest Metabolic Stress.
    J Am Coll Cardiol. 2017;69:2314-2316.
    >> Share

  287. NIEDERSEER D, Stadlmayr A, Huber-Schonauer U, Ploderl M, et al
    Cardiovascular Risk and Known Coronary Artery Disease Are Associated With Colorectal Adenoma and Advanced Neoplasia.
    J Am Coll Cardiol. 2017;69:2348-2350.
    >> Share

  288. FANAROFF AC, James SK, Weisz G, Prather K, et al
    Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial.
    J Am Coll Cardiol. 2017;69:2304-2313.
    >> Share

  289. LLOYD-JONES DM, Allen NB
    Childhood Cardiovascular Risk Factors and Midlife Cognitive Performance: Time to Act on Primordial Prevention.
    J Am Coll Cardiol. 2017;69:2290-2292.
    >> Share

  290. ROVIO SP, Pahkala K, Nevalainen J, Juonala M, et al
    Cardiovascular Risk Factors From Childhood and Midlife Cognitive Performance: The Young Finns Study.
    J Am Coll Cardiol. 2017;69:2279-2289.
    >> Share

  291. LEMESLE G, Tricot O, Meurice T, Lallemant R, et al
    Incident Myocardial Infarction and Very Late Stent Thrombosis in Outpatients With Stable Coronary Artery Disease.
    J Am Coll Cardiol. 2017;69:2149-2156.
    >> Share

  292. BARRABES JA, Garcia Del Blanco B, Garcia-Dorado D
    On the Stability of Stable Coronary Artery Disease.
    J Am Coll Cardiol. 2017;69:2157-2159.
    >> Share

    April 2017
  293. FARKOUH ME
    CABG Versus PCI for Complex Coronary Disease: Time to Close the Books.
    J Am Coll Cardiol. 2017;69:2051-2053.
    >> Share

  294. BARWARI T, Joshi A, Mayr M
    Reply: The Complex miRNAs-p53 Signaling Network in Cardiovascular Disease.
    J Am Coll Cardiol. 2017;69:2100.
    >> Share

  295. PATANE S
    The Complex miRNAs-p53 Signaling Network in Cardiovascular Disease.
    J Am Coll Cardiol. 2017;69:2099-2100.
    >> Share

  296. KIM EK, Park TK, Yang JH, Song YB, et al
    Ticagrelor Versus Clopidogrel on Myocardial Infarct Size in Patients Undergoing Primary Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2017;69:2098-2099.
    >> Share

  297. ABDALLAH MS, Wang K, Magnuson EA, Osnabrugge RL, et al
    Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease.
    J Am Coll Cardiol. 2017;69:2039-2050.
    >> Share

  298. PALMERINI T, Bacchi Reggiani L, Della Riva D, Romanello M, et al
    Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting.
    J Am Coll Cardiol. 2017;69:2011-2022.
    >> Share

  299. POSS J, Koster J, Fuernau G, Eitel I, et al
    Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction.
    J Am Coll Cardiol. 2017;69:1913-1920.
    >> Share

  300. PANENI F, Diaz Canestro C, Libby P, Luscher TF, et al
    The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels.
    J Am Coll Cardiol. 2017;69:1952-1967.
    >> Share

  301. BAVRY AA
    Non-ST-Segment Elevation Acute Coronary Syndromes: Lessons Learned Over the Last Decade.
    J Am Coll Cardiol. 2017;69:1894-1896.
    >> Share

  302. HOEDEMAKER NP, Damman P, Woudstra P, Hirsch A, et al
    Early Invasive Versus Selective Strategy for Non-ST-Segment Elevation Acute Coronary Syndrome: The ICTUS Trial.
    J Am Coll Cardiol. 2017;69:1883-1893.
    >> Share

  303. JORGENSEN ME, Andersson C, Norgaard BL, Abdulla J, et al
    Functional Testing or Coronary Computed Tomography Angiography in Patients With Stable Coronary Artery Disease.
    J Am Coll Cardiol. 2017;69:1761-1770.
    >> Share

  304. SOM S
    Deficiencies in Global Health Training for Cardiovascular Fellows.
    J Am Coll Cardiol. 2017;69:1748-1752.
    >> Share

  305. BARRA S, Boveda S, Providencia R, Sadoul N, et al
    Adding Defibrillation Therapy to Cardiac Resynchronization on the Basis of the Myocardial Substrate.
    J Am Coll Cardiol. 2017;69:1669-1678.
    >> Share

    March 2017
  306. STITZIEL NO, Khera AV, Wang X, Bierhals AJ, et al
    ANGPTL3 Deficiency and Protection Against Coronary Artery Disease.
    J Am Coll Cardiol. 2017 Mar 29. pii: S0735-1097(17)30703.
    >> Share

  307. NAMASIVAYAM M, McCready M, Adji A, O'Rourke MF, et al
    The Role of Heart Rate in Diastolic Coronary Perfusion and Subclinical Myocardial Ischemia.
    J Am Coll Cardiol. 2017;69:1647.
    >> Share

  308. SPENCE JD
    Diastolic Hypotension and Myocardial Ischemia: A Reason to Remember Cuff Artifact in Blood Pressure Measurement.
    J Am Coll Cardiol. 2017;69:1646-1647.
    >> Share

  309. CHEEZUM MK, Liberthson RR, Shah NR, Villines TC, et al
    Anomalous Aortic Origin of a Coronary Artery From the Inappropriate Sinus of Valsalva.
    J Am Coll Cardiol. 2017;69:1592-1608.
    >> Share

  310. O'CONNOR CM, Whellan DJ, Fiuzat M, Punjabi NM, et al
    Cardiovascular Outcomes With Minute Ventilation-Targeted Adaptive Servo-Ventilation Therapy in Heart Failure: The CAT-HF Trial.
    J Am Coll Cardiol. 2017;69:1577-1587.
    >> Share

  311. YAN AT, Koh M, Chan KK, Guo H, et al
    Association Between Cardiovascular Risk Factors and Aortic Stenosis: The CANHEART Aortic Stenosis Study.
    J Am Coll Cardiol. 2017;69:1523-1532.
    >> Share

  312. LAU ES, Braunwald E, Murphy SA, Wiviott SD, et al
    Potent P2Y12 Inhibitors in Men Versus Women: A Collaborative Meta-Analysis of Randomized Trials.
    J Am Coll Cardiol. 2017;69:1549-1559.
    >> Share

  313. SERBAN MC, Colantonio LD, Manthripragada AD, Monda KL, et al
    Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction.
    J Am Coll Cardiol. 2017;69:1386-1395.
    >> Share

  314. VERBEEK R, Sandhu MS, Hovingh GK, Sjouke B, et al
    Lipoprotein(a) Improves Cardiovascular Risk Prediction Based on Established Risk Algorithms.
    J Am Coll Cardiol. 2017;69:1513-1515.
    >> Share

  315. SCIAHBASI A, Frigoli E, Sarandrea A, Rothenbuhler M, et al
    Radiation Exposure and Vascular Access in Acute Coronary Syndromes: The RADMatrix Trial.
    J Am Coll Cardiol. 2017 Mar 15. pii: S0735-1097(17)36042.
    >> Share

  316. HANNAN EL, Samadashvili Z, Cozzens K, Gesten F, et al
    Changes in Percutaneous Coronary Interventions Deemed "Inappropriate" by Appropriate Use Criteria.
    J Am Coll Cardiol. 2017;69:1234-1242.
    >> Share

  317. MANTEL A, Holmqvist M, Andersson DC, Lund LH, et al
    Association Between Rheumatoid Arthritis and Risk of Ischemic and Nonischemic Heart Failure.
    J Am Coll Cardiol. 2017;69:1275-1285.
    >> Share

  318. PATEL MR, Calhoon JH, Dehmer GJ, Grantham JA, et al
    ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association f
    J Am Coll Cardiol. 2017 Mar 9. pii: S0735-1097(17)30385.
    >> Share

  319. DEBOER MD, Gurka MJ, Golden SH, Musani SK, et al
    Independent Associations Between Metabolic Syndrome Severity and Future Coronary Heart Disease by Sex and Race.
    J Am Coll Cardiol. 2017;69:1204-1205.
    >> Share

  320. KRONISH IM, Diaz KM, Goldsmith J, Moise N, et al
    Objectively Measured Adherence to Physical Activity Guidelines After Acute Coronary Syndrome.
    J Am Coll Cardiol. 2017;69:1205-1207.
    >> Share

  321. LIPEROTI R, Vetrano DL, Bernabei R, Onder G, et al
    Herbal Medications in Cardiovascular Medicine.
    J Am Coll Cardiol. 2017;69:1188-1199.
    >> Share

  322. FREEMAN AM, Morris PB, Barnard N, Esselstyn CB, et al
    Trending Cardiovascular Nutrition Controversies.
    J Am Coll Cardiol. 2017;69:1172-1187.
    >> Share

  323. SHAH AD, Denaxas S, Nicholas O, Hingorani AD, et al
    Neutrophil Counts and Initial Presentation of 12 Cardiovascular Diseases: A CALIBER Cohort Study.
    J Am Coll Cardiol. 2017;69:1160-1169.
    >> Share

  324. VOGEL RA
    Biomarkers of High-Grade Coronary Stenosis: Searching for Seventies.
    J Am Coll Cardiol. 2017;69:1157-1159.
    >> Share

  325. IBRAHIM NE, Januzzi JL Jr, Magaret CA, Gaggin HK, et al
    A Clinical and Biomarker Scoring System to Predict the Presence of Obstructive Coronary Artery Disease.
    J Am Coll Cardiol. 2017;69:1147-1156.
    >> Share

  326. GAZIANO TA
    Lifestyle and Cardiovascular Disease: More Work to Do.
    J Am Coll Cardiol. 2017;69:1126-1128.
    >> Share

  327. LV J, Yu C, Guo Y, Bian Z, et al
    Adherence to Healthy Lifestyle and Cardiovascular Diseases in the Chinese Population.
    J Am Coll Cardiol. 2017;69:1116-1125.
    >> Share

  328. ESTRUCH R, Ros E
    Nutrition Intervention on Cardiovascular Risk Factors in Healthy Individuals: Glass Half Empty or Half Full?
    J Am Coll Cardiol. 2017;69:1113-1115.
    >> Share

  329. JENKINS DJ, Boucher BA, Ashbury FD, Sloan M, et al
    Effect of Current Dietary Recommendations on Weight Loss and Cardiovascular Risk Factors.
    J Am Coll Cardiol. 2017;69:1103-1112.
    >> Share

    February 2017
  330. ZHAO DF, Edelman JJ, Seco M, Bannon PG, et al
    Coronary Artery Bypass Grafting With and Without Manipulation of the Ascending Aorta: A Network Meta-Analysis.
    J Am Coll Cardiol. 2017;69:924-936.
    >> Share

  331. MESSERLI FH, Rimoldi SF, Bangalore S, Bavishi C, et al
    Reply: Heart Rate Reduction and Cardiovascular Outcome in Hypertension.
    J Am Coll Cardiol. 2017;69:1100-1101.
    >> Share

  332. PALATINI P
    Heart Rate Reduction and Cardiovascular Outcome in Hypertension.
    J Am Coll Cardiol. 2017;69:1099-1100.
    >> Share

  333. MASHAYEKHI K, Neuser H, Kraus A, Zimmer M, et al
    Successful Percutaneous Coronary Intervention Improves Cardiopulmonary Exercise Capacity in Patients With Chronic Total Occlusions.
    J Am Coll Cardiol. 2017;69:1095-1096.
    >> Share

  334. BOHULA EA, Morrow DA, Giugliano RP, Blazing MA, et al
    Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention.
    J Am Coll Cardiol. 2017;69:911-921.
    >> Share

  335. RADER DJ, Bajaj A, Khetarpal SA
    Deep Apolipoprotein Proteomics to Uncover Mechanisms of Coronary Disease Risk.
    J Am Coll Cardiol. 2017;69:801-804.
    >> Share

  336. KIM J
    Big Data, Health Informatics, and the Future of Cardiovascular Medicine.
    J Am Coll Cardiol. 2017;69:899-902.
    >> Share

  337. JAVAHERI S, Barbe F, Campos-Rodriguez F, Dempsey JA, et al
    Sleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences.
    J Am Coll Cardiol. 2017;69:841-858.
    >> Share

  338. KOVACIC JC
    Unraveling the Complex Genetics of Coronary Artery Disease.
    J Am Coll Cardiol. 2017;69:837-840.
    >> Share

  339. WEBB TR, Erdmann J, Stirrups KE, Stitziel NO, et al
    Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease.
    J Am Coll Cardiol. 2017;69:823-836.
    >> Share

  340. PECHLANER R, Tsimikas S, Yin X, Willeit P, et al
    Very-Low-Density Lipoprotein-Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III.
    J Am Coll Cardiol. 2017;69:789-800.
    >> Share

  341. LEE PH, Park DW, Park SJ
    Reply: The Unforgettable Cornerstone: Role of Ticlopidine in Developing Current Antithrombotic Treatment After Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2017;69:756-757.
    >> Share

  342. COLOMBO A, Ancona MB, Chieffo A
    The Unforgettable Cornerstone: Role of Ticlopidine in Developing Current Antithrombotic Treatment After Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2017;69:755-756.
    >> Share

  343. LANSKY AJ, Messe SR, Brickman AM, Dwyer M, et al
    Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative.
    J Am Coll Cardiol. 2017;69:679-691.
    >> Share

  344. SINGH M, Prati F
    Exploring the Coronary Artery Wall From the Luminal Side: For Specialists or for All Cardiologists?
    J Am Coll Cardiol. 2017;69:658-660.
    >> Share

  345. CHHATRIWALLA AK, Rader DJ
    Intracoronary Imaging, Reverse Cholesterol Transport, and Transcriptomics: Precision Medicine in CAD?
    J Am Coll Cardiol. 2017;69:641-643.
    >> Share

  346. MOLITERNO DJ, Ziada KM
    More Time to SORT OUT Clinical Outcomes After First-Generation Drug-Eluting Stents: Related Versus Unrelated Events.
    J Am Coll Cardiol. 2017;69:625-627.
    >> Share

  347. GALLOE AM, Kelbaek H, Thuesen L, Hansen HS, et al
    10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents.
    J Am Coll Cardiol. 2017;69:616-624.
    >> Share

  348. KINI AS, Vengrenyuk Y, Yoshimura T, Matsumura M, et al
    Fibrous Cap Thickness by Optical Coherence Tomography In Vivo.
    J Am Coll Cardiol. 2017;69:644-657.
    >> Share

  349. BANSILAL S, Fuster V
    Reply: Medication Adherence and Cardiovascular Outcomes.
    J Am Coll Cardiol. 2017;69:599-600.
    >> Share

  350. FARIDI KF
    Medication Adherence and Cardiovascular Outcomes.
    J Am Coll Cardiol. 2017;69:598-599.
    >> Share

  351. CAVALCANTE R, Sotomi Y, Lee CW, Ahn JM, et al
    Reply: Percutaneous Revascularization of Left Main Disease: Could the Angiographic Follow-Up Improve the Survival?
    J Am Coll Cardiol. 2017;69:598.
    >> Share

  352. LOZANO I, Rondan J, Vegas JM, Segovia E, et al
    Percutaneous Revascularization of Left Main Disease: Could the Angiographic Follow-Up Improve the Survival?
    J Am Coll Cardiol. 2017;69:597-598.
    >> Share

    January 2017
  353. IKENO F, Brooks MM, Nakagawa K, Kim MK, et al
    SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial.
    J Am Coll Cardiol. 2017;69:395-403.
    >> Share

  354. ELZE MC, Gregson J, Baber U, Williamson E, et al
    Comparison of Propensity Score Methods and Covariate Adjustment: Evaluation in 4 Cardiovascular Studies.
    J Am Coll Cardiol. 2017;69:345-357.
    >> Share

  355. SEALS AA, Chazal RA
    Promoting Initiatives in Quality of Cardiovascular Care: The Complementary Role of ACC National and State Chapters.
    J Am Coll Cardiol. 2017 Jan 19. pii: S0735-1097(17)30015.
    >> Share

  356. ROLLINI F, Franchi F, Angiolillo DJ
    Reply: Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study.
    J Am Coll Cardiol. 2017;69:250-251.
    >> Share

  357. KIM WY
    Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study.
    J Am Coll Cardiol. 2017;69:249-250.
    >> Share

  358. BAUER L, Kern S, Rogacev KS, Emrich IE, et al
    HDL Cholesterol Efflux Capacity and Cardiovascular Events in Patients With Chronic Kidney Disease.
    J Am Coll Cardiol. 2017;69:246-247.
    >> Share

  359. VADUGANATHAN M, Harrington RA, Stone GW, Deliargyris EN, et al
    Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2017;69:176-185.
    >> Share

  360. FESKE SK
    A New Treatable Risk Factor for Stroke and Atherosclerotic Cardiovascular Disease?
    J Am Coll Cardiol. 2017;69:159-161.
    >> Share

  361. ISHIKAWA K
    The Transgenic Diabetic Pig Heart: A "Sweet Heart" for Translational Cardiovascular Research.
    J Am Coll Cardiol. 2017;69:144-146.
    >> Share

  362. BYUN YS, Yang X, Bao W, DeMicco D, et al
    Oxidized Phospholipids on Apolipoprotein B-100 and Recurrent Ischemic Events Following Stroke or Transient Ischemic Attack.
    J Am Coll Cardiol. 2017;69:147-158.
    >> Share

  363. HINKEL R, Hoewe A, Renner S, Ng J, et al
    Diabetes Mellitus-Induced Microvascular Destabilization in the Myocardium.
    J Am Coll Cardiol. 2017;69:131-143.
    >> Share

  364. VAN DIEPEN S, Fuster V, Verma S, Hamza TH, et al
    Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights.
    J Am Coll Cardiol. 2017;69:119-127.
    >> Share

  365. GAROT P, Morice MC, Tresukosol D, Pocock SJ, et al
    2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents.
    J Am Coll Cardiol. 2017;69:162-171.
    >> Share

  366. VACHIAT A, McCutcheon K, Tsabedze N, Zachariah D, et al
    HIV and Ischemic Heart Disease.
    J Am Coll Cardiol. 2017;69:73-82.
    >> Share

  367. SARMA AA, Nkonde-Price C, Gulati M, Duvernoy CS, et al
    Cardiovascular Medicine and Society: The Pregnant Cardiologist.
    J Am Coll Cardiol. 2017;69:92-101.
    >> Share

  368. CHANG M, Ahn JM, Lee CW, Cavalcante R, et al
    Reply: Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease.
    J Am Coll Cardiol. 2017;69:117-118.
    >> Share

  369. FERNANDEZ-PEREIRA C, Mieres J, Rodriguez AE
    Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease.
    J Am Coll Cardiol. 2017;69:116-117.
    >> Share

  370. POURDJABBAR A, Hibbert B, Patel MP, Reeves RR, et al
    Incomplete Revascularization: The Achilles Heel of Percutaneous Coronary Interventions.
    J Am Coll Cardiol. 2017;69:115-116.
    >> Share

    December 2016
  371. MCNAMARA RL, Spertus JA
    Reply: Risk Prediction in Acute Myocardial Infarction.
    J Am Coll Cardiol. 2016;68:2919.
    >> Share

  372. HUDZIK B, Lekston A, Gasior M
    Risk Prediction in Acute Myocardial Infarction.
    J Am Coll Cardiol. 2016;68:2918-2919.
    >> Share

  373. FORD I, Shah AS, Zhang R, McAllister DA, et al
    High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease.
    J Am Coll Cardiol. 2016;68:2719-2728.
    >> Share

  374. USSHER JR, Elmariah S, Gerszten RE, Dyck JR, et al
    The Emerging Role of Metabolomics in the Diagnosis and Prognosis of Cardiovascular Disease.
    J Am Coll Cardiol. 2016;68:2850-2870.
    >> Share

  375. MARIAN AJ, van Rooij E, Roberts R
    Genetics and Genomics of Single-Gene Cardiovascular Diseases: Common Hereditary Cardiomyopathies as Prototypes of Single-Gene Disorders.
    J Am Coll Cardiol. 2016;68:2831-2849.
    >> Share

  376. LAM MP, Ping P, Murphy E
    Proteomics Research in Cardiovascular Medicine and Biomarker Discovery.
    J Am Coll Cardiol. 2016;68:2819-2830.
    >> Share

  377. ASSIMES TL, Roberts R
    Genetics: Implications for Prevention and Management of Coronary Artery Disease.
    J Am Coll Cardiol. 2016;68:2797-2818.
    >> Share

  378. FATTAH C, Nather K, McCarroll CS, Hortigon-Vinagre MP, et al
    Gene Therapy With Angiotensin-(1-9) Preserves Left Ventricular Systolic Function After Myocardial Infarction.
    J Am Coll Cardiol. 2016;68:2652-2666.
    >> Share

  379. EGHOLM G, Kristensen SD, Thim T, Olesen KK, et al
    Risk Associated With Surgery Within 12 Months After Coronary Drug-Eluting Stent Implantation.
    J Am Coll Cardiol. 2016;68:2622-2632.
    >> Share

  380. LEE MS, Gordin JS
    Bleeding Complications Before Angiography in Non-ST-Segment Elevation Acute Coronary Syndrome Patients: Insights From ACUITY.
    J Am Coll Cardiol. 2016;68:2619-2621.
    >> Share

  381. REDFORS B, Kirtane AJ, Pocock SJ, Ayele GM, et al
    Bleeding Events Before Coronary Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.
    J Am Coll Cardiol. 2016;68:2608-2618.
    >> Share

  382. MASOUDI FA, Ponirakis A, de Lemos JA, Jollis JG, et al
    Executive Summary: Trends in U.S. Cardiovascular Care: 2016 Report from 4 ACC National Cardiovascular Data Registries.
    J Am Coll Cardiol. 2016 Dec 20. pii: S0735-1097(16)37337.
    >> Share

  383. MASOUDI FA, Ponirakis A, de Lemos JA, Jollis JG, et al
    Trends in U.S. Cardiovascular Care: 2016 Report from 4 ACC National Cardiovascular Data Registries.
    J Am Coll Cardiol. 2016 Dec 20. pii: S0735-1097(16)37338.
    >> Share

  384. PATEL MR, Calhoon JH, Dehmer GJ, Grantham JA, et al
    ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Th
    J Am Coll Cardiol. 2016 Dec 14. pii: S0735-1097(16)36782.
    >> Share

  385. EGBE AC, Warnes CA
    Cardiovascular Adverse Events After Aortic Valve Replacement in Mixed Aortic Valve Disease: Beyond Ejection Fraction.
    J Am Coll Cardiol. 2016;68:2591-2593.
    >> Share

  386. VAN KRUIJSDIJK RC, van der Graaf Y, Algra A, de Borst GJ, et al
    The Effects of Secondary Cardiovascular Prevention on Cancer Risk in Patients With Manifest Vascular Disease.
    J Am Coll Cardiol. 2016;68:2588-2589.
    >> Share

  387. BARWARI T, Joshi A, Mayr M
    MicroRNAs in Cardiovascular Disease.
    J Am Coll Cardiol. 2016;68:2577-2584.
    >> Share

  388. KULANDAVELU S, Karantalis V, Fritsch J, Hatzistergos KE, et al
    Pim1 Kinase Overexpression Enhances ckit+ Cardiac Stem Cell Cardiac Repair Following Myocardial Infarction in Swine.
    J Am Coll Cardiol. 2016;68:2454-2464.
    >> Share

  389. GORE MO, McGuire DK
    A Test in Context: Hemoglobin A1c and Cardiovascular Disease.
    J Am Coll Cardiol. 2016;68:2479-2486.
    >> Share

  390. ARBAB-ZADEH A, Fuster V
    The Risk Continuum of Atherosclerosis and its Implications for Defining CHD by Coronary Angiography.
    J Am Coll Cardiol. 2016;68:2467-2478.
    >> Share

    November 2016
  391. GESKE JB, Anavekar NS, Nishimura RA, Oh JK, et al
    Differentiation of Constriction and Restriction: Complex Cardiovascular Hemodynamics.
    J Am Coll Cardiol. 2016;68:2329-2347.
    >> Share

  392. NDREPEPA G, Colleran R, Braun S, Cassese S, et al
    High-Sensitivity Troponin T and Mortality After Elective Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68:2259-2268.
    >> Share

  393. BARBATO E, Toth GG, Johnson NP, Pijls NH, et al
    A Prospective Natural History Study of Coronary Atherosclerosis Using Fractional Flow Reserve.
    J Am Coll Cardiol. 2016;68:2247-2255.
    >> Share

  394. BEYGUI F, Montalescot G
    Reply: Mineralocorticoid Receptor Antagonism in Acute Myocardial Infarction: Who Benefits?
    J Am Coll Cardiol. 2016;68:2241-2242.
    >> Share

  395. WEIR RA, Petrie CJ
    Mineralocorticoid Receptor Antagonism in Acute Myocardial Infarction: Who Benefits?
    J Am Coll Cardiol. 2016;68:2240-2241.
    >> Share

  396. DWECK MR, Williams MC, Moss AJ, Newby DE, et al
    Computed Tomography and Cardiac Magnetic Resonance in Ischemic Heart Disease.
    J Am Coll Cardiol. 2016;68:2201-2216.
    >> Share

  397. MOSS AJ
    Multicenter Cardiovascular Studies and Trials: Lessons Learned From 35 Years of Productive Collaboration.
    J Am Coll Cardiol. 2016;68:2232-2234.
    >> Share

  398. DYKUN I, Lehmann N, Kalsch H, Mohlenkamp S, et al
    Statin Medication Enhances Progression of Coronary Artery Calcification: The Heinz Nixdorf Recall Study.
    J Am Coll Cardiol. 2016;68:2123-2125.
    >> Share

  399. FENTANES E, Wessman D, Villines TC, Steel KE, et al
    Serving to Heal and Honored to Serve: An Insight Into Military Cardiovascular Fellowship.
    J Am Coll Cardiol. 2016;68:2118-2121.
    >> Share

  400. FLEGO D, Liuzzo G, Weyand CM, Crea F, et al
    Adaptive Immunity Dysregulation in Acute Coronary Syndromes: From Cellular and Molecular Basis to Clinical Implications.
    J Am Coll Cardiol. 2016;68:2107-2117.
    >> Share

  401. KO DT, Alter DA, Guo H, Koh M, et al
    High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions: The CANHEART Study.
    J Am Coll Cardiol. 2016;68:2073-2083.
    >> Share

  402. FRANKLIN SS, Thijs L, Asayama K, Li Y, et al
    The Cardiovascular Risk of White-Coat Hypertension.
    J Am Coll Cardiol. 2016;68:2033-2043.
    >> Share

  403. RACCA V, Rovaris M, Vaini E, Cavarretta R, et al
    6-Month Effects of Fingolimod on Indexes of Cardiovascular Autonomic Control in Multiple Sclerosis.
    J Am Coll Cardiol. 2016;68:2027-2029.
    >> Share

  404. FEINSTEIN MJ, Mitter SS, Yadlapati A, Achenbach CJ, et al
    HIV-Related Myocardial Vulnerability to Infarction and Coronary Artery Disease.
    J Am Coll Cardiol. 2016;68:2026-2027.
    >> Share

  405. HATA R, Kadota K, Hyodo Y, Otsuru S, et al
    TCT-243 Second generation drug-eluting stents or coronary bypass surgery in patients with three-vessel coronary disease.
    J Am Coll Cardiol. 2016;68.
    >> Share

  406. SINGH S, Ahsan L, Grayver E, Rosen S, et al
    TCT-197 Women Received Delayed Admission ECG with Typical Symptom Presentation in ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    >> Share

  407. YUDI M, Andrianopoulos N, O'Brien J, Selkrig L, et al
    TCT-195 Predictors of Recurrent Acute Coronary Syndrome Hospitalisations Following Acute Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    >> Share

  408. REMKES W, Roolvink V, Rasoul S, Dambrink JH, et al
    TCT-193 Zotarolimus eluting stent compared with GENOUS stent in patients with ST-elevation myocardial infarction undergoing primary PCI.
    J Am Coll Cardiol. 2016;68.
    >> Share

  409. GAAFAR A, Al Kabbany A, El Shedoudy S, Badr S, et al
    TCT-190 The value of QRS duration as a marker of myocardial reperfusion in patient with acute ST-segment elevation myocardial infarction treated with primary percutaneous intervention.
    J Am Coll Cardiol. 2016;68.
    >> Share

  410. SHIN H, Jang JS, Jin HY, Seo JS, et al
    TCT-192 Combined Use of Neutrophil to Lymphocyte Ratio and C-Reactive Protein to predict Clinical Outcomes in Acute Myocardial Infarction Patients undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    >> Share

  411. MAHMOUD A, Elgendy A, Mansoor H, Mojadidi M, et al
    TCT-191 Intravenous beta-blockers for Patients with ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Meta-analysis of Randomized Trials.
    J Am Coll Cardiol. 2016;68.
    >> Share

  412. BAEK JY, Rha SW, Choi BG, Byun JK, et al
    TCT-189 Comparison of 5-year Clinical Outcomes between Stabilized Acute Myocardial Infarction Patients following Percutaneous Coronary Intervention and the Patients with Angina Pectoris.
    J Am Coll Cardiol. 2016;68.
    >> Share

  413. ELIAS J, van Dongen I, Hoebers L, Ouweneel D, et al
    TCT-188 The impact of the location on left ventricular function in ST-elevation Myocardial Infarction patients with a chronic total occlusion in a non-infarct related artery treated with percutaneous coronary intervention.
    J Am Coll Cardiol. 2016;68.
    >> Share

  414. ANANTHA NARAYANAN M, Reddy YN, Gujjula N, Anugula D, et al
    TCT-186 Delayed versus immediate stenting strategy in ST segment elevation myocardial infarction - A meta analysis.
    J Am Coll Cardiol. 2016;68.
    >> Share

  415. JANG JH, Kim DK, Song PS, Kim DI, et al
    TCT-185 Influence of total ischemic time on clinical outcomes and efficacy of manual thrombus aspiration during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Analysis from the POST trial.
    J Am Coll Cardiol. 2016;68.
    >> Share

  416. RHEE TM, Lee JM, Hwang D, Park J, et al
    TCT-183 Deferred versus Conventional stent implantation in patients with acute ST-segment elevation myocardial infarction: an updated meta-analysis of 10 Studies.
    J Am Coll Cardiol. 2016;68.
    >> Share

  417. BARDOOLI F, McAlindon E, Littlejohns B, Suleiman MS, et al
    TCT-184 Early changes in circulating miRNA 133a are indicative of cardiac remodelling after 3 months in patients presenting with acute ST elevation myocardial infarction.
    J Am Coll Cardiol. 2016;68.
    >> Share

  418. GIUSTINO G, Mehran R, Kirtane A, Redfors B, et al
    TCT-181 Temporal Differences in Ischemic and Bleeding Risks after Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    >> Share

  419. SCHENK R, Nix D
    TCT-180 Impact of the novel DPP-IV-inhibitor Dutogliptin in combination with G-CSF on survival rates and cardiac remodelling after acute myocardial infarction.
    J Am Coll Cardiol. 2016;68.
    >> Share

  420. HER AY, Rha SW, Kim YH, Choi BG, et al
    TCT-182 Impact of Gender and Age on Long-term Mortality in Acute Myocardial Infarction Patients with Anemia.
    J Am Coll Cardiol. 2016;68.
    >> Share

  421. MOVAHED MR, Hashemzadeh M
    TCT-177 Obesity is independently associated with occurrence of ST elevation myocardial infarction with steady decline of this association over the recent years.
    J Am Coll Cardiol. 2016;68.
    >> Share

  422. SGUEGLIA G, Gioffre G, De Santis A, D'Errico F, et al
    TCT-178 Feasibility and safety of the "the one small catheter only" (TOSCO) strategy in patients with ST elevation myocardial infarction.
    J Am Coll Cardiol. 2016;68.
    >> Share

  423. HIGASHIHARA T, Dote K, Kato M, Sasaki S, et al
    TCT-175 Myocardial Wash Grade in Evaluation of Reperfusion Therapy in Acute Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    >> Share

  424. YUDI M, Farouque O, Ajani A, Brennan A, et al
    TCT-176 Clinical Outcomes of Patients Receiving Pre-treatment with Dual Anti-platelet Therapy in ST-Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    >> Share

  425. BESSONOV I, Zyrianov I, Kuznetsov V, Sapozhnikov S, et al
    TCT-174 Impact of Direct Stenting on In-Hospital Outcomes in Patients with ST-Elevation Myocardial Infarction and Hyperglycemia.
    J Am Coll Cardiol. 2016;68.
    >> Share

  426. LARSON D, Garberich R, Lips D, Burke MN, et al
    TCT-173 Safety of Very Early (< 3hrs) Routine Percutaneous Coronary Intervention after Fibrinolysis in ST-segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    >> Share

  427. VAN HOUWELINGEN KG, van der Heijden L, Lam MK, Lowik M, et al
    TCT-170 Clinical Outcome After Myocardial Infarction Treated With Resolute Integrity and Promus Element Stents: Insights From DUTCH PEERS (TWENTE II) Randomized Trial.
    J Am Coll Cardiol. 2016;68.
    >> Share

  428. YAMADA T, Mizuguchi Y, Takahashi A, Shibutani H, et al
    TCT-169 The impact of a door-to-balloon time of less than 30 minutes on the in-hospital mortality in patients with ST elevation myocardial infarction.
    J Am Coll Cardiol. 2016;68.
    >> Share

  429. GIUSTINO G, Redfors B, Brener S, Kirtane A, et al
    TCT-166 Correlates and Prognostic Impact of New-Onset Heart Failure after ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Insights from the INFUSE-AMI Trial.
    J Am Coll Cardiol. 2016;68.
    >> Share

  430. LEE JH, Choi KU, Kim U, Lee CH, et al
    TCT-167 Clinical impact of body mass index in old age patients with acute myocardial infarction.
    J Am Coll Cardiol. 2016;68.
    >> Share

  431. DE WAARD G, Fahrni G, de Wit D, Kitabata H, et al
    TCT-165 Hyperemic microvascular resistance is a predictor of clinical outcome after revascularization for acute myocardial infarction: A patient-level pooled analysis.
    J Am Coll Cardiol. 2016;68.
    >> Share

  432. VLACHOJANNIS G, Paradies V, Hofma SH, Togni M, et al
    TCT-161 5 years follow-up of biolimus eluting stents versus everolimus eluting in ST-segment elevation myocardial infarction presenting patients: Results from Compare II trial.
    J Am Coll Cardiol. 2016;68.
    >> Share

  433. SAIB A, Payot L, Kerneis M, Barthelemy O, et al
    TCT-160 Impact of admission during ON vs. OFF hours in unselected ST-Elevation Myocardial Infarction Patients treated with Primary Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    >> Share

  434. VILLABLANCA P, Makkiya M, Mohananey D, Lesniak-Sobelga A, et al
    TCT-159 Impact of Staged versus One-Time Multivessel Percutaneous Intervention in ST-elevation Myocardial Infarction: A Meta-analysis.
    J Am Coll Cardiol. 2016;68.
    >> Share

  435. LOBO MG, Dipp T, Petry I, Schmidt K, et al
    TCT-158 Treating Periodontal Disease in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial.
    J Am Coll Cardiol. 2016;68.
    >> Share

  436. VELAGAPUDI P, Turagam M, Katta N, Mittal M, et al
    TCT-154 Multivessel Revascularization versus Culprit Vessel Only Revascularization in Patients with ST-Elevation Myocardial Infarction and multivessel disease: An Updated Meta-analaysis.
    J Am Coll Cardiol. 2016;68.
    >> Share

  437. SONG Y, Ma YL, Zhang JH, Tang XF, et al
    TCT-155 Prognostic Impact of the Residual SYNTAX Score on 2-years Outcomes in Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    >> Share

  438. JANG WJ, Song YB, Yang JH, Gwon HC, et al
    TCT-152 Clinical Significance of Post-infarct Fever in ST-segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Imaging Study.
    J Am Coll Cardiol. 2016;68.
    >> Share

  439. KOIFMAN E, Garcia-Garcia HM, Kiramijyan S, Negi S, et al
    TCT-153 Acute Stroke During Primary Percutaneous Coronary Intervention For ST Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    >> Share

  440. GUTTMANN O, Perera D, Jain A, Mathur A, et al
    TCT-146 Routine Aspiration thrombectomy is associated with increased stroke rates during primary percutaneous coronary intervention for myocardial infarction.
    J Am Coll Cardiol. 2016;68.
    >> Share

  441. HAMZA M, Shehata M
    TCT-147 Local intracoronary delivery of eptifibatide plus verapamil via thrombus aspiration catheter to prevent No-reflow in acute ST elevation myocardial infarction patients with large thrombus burden.
    J Am Coll Cardiol. 2016;68.
    >> Share

  442. VERGARA R, Valenti R, Migliorini A, Parodi G, et al
    TCT-145 Rheolytic Thrombectomy for Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    J Am Coll Cardiol. 2016;68.
    >> Share

  443. VOUDRIS K, Vidovich M
    TCT-143 Outcomes of Percutaneous Coronary Intervention for Acute Myocardial Infarction in patients with history of Malignancy.
    J Am Coll Cardiol. 2016;68.
    >> Share

  444. VOUDRIS K, Vidovich M
    TCT-141 Percutaneous Coronary Intervention (PCI) for Acute Myocardial Infarction in patients with Systemic lupus erythematosus: analysis from Nationwide Inpatient Sample (NIS).
    J Am Coll Cardiol. 2016;68.
    >> Share

  445. DE LA TORRE HERNANDEZ JM, Gomez Hospital JA, Brugaletta S, Baz JA, et al
    TCT-137 Influence of non-culprit lesions management on outcomes in patients over 75 years old with ST elevated myocardial infarction. Results from the ESTROFA MI+75 nation-wide registry.
    J Am Coll Cardiol. 2016;68.
    >> Share

  446. HAMZA M, Elgendy I
    TCT-139 A randomized trial of complete versus culprit-only revascularization during primary percutaneous coronary intervention in diabetic patients with acute ST elevation myocardial infarction and multi vessel disease.
    J Am Coll Cardiol. 2016;68.
    >> Share

  447. CID ALVAREZ AB, Galvao Braga C, Redondo Dieguez A, Trillo R, et al
    TCT-138 Multivessel versus culprit-only percutaneous coronary intervention in ST-segment elevation myocardial infarction: analysis of a 8 year-all-comers registry.
    J Am Coll Cardiol. 2016;68.
    >> Share

  448. MERAJ P, Maini B, Mascari P, Jauhar R, et al
    TCT-131 Survival Benefit when using Impella 2.5 Percutaneous LVAD prior to PCI of Unprotected Left Main Culprit Vessel in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    J Am Coll Cardiol. 2016;68.
    >> Share

  449. LEURENT G, Garlantezec R, Auffret V, Filippi E, et al
    TCT-130 Complete Myocardial Revascularisation is not Associated with a Better Prognosis in Cardiogenic Shock Complicating ST-Elevation Myocardial Infarction. Insight from the multicenter prospective ORBI registry.
    J Am Coll Cardiol. 2016;68.
    >> Share

  450. BASIR M, Khandelwal A, Dixon S, Moses J, et al
    TCT-121 Mechanical Circulatory Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Insights from the cVAD Registry.
    J Am Coll Cardiol. 2016;68.
    >> Share

  451. VERGARA R, Valenti R, Migliorini A, Parodl G, et al
    TCT-119 A New Risk Score to Predict Long-Term Cardiac Mortality in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock and Treated with Primary Percutaneous Intervention.
    J Am Coll Cardiol. 2016;68.
    >> Share

  452. RATHOD K, Mathur A, Wragg A, O'Mahony C, et al
    TCT-117 Impact of Intra-aortic Balloon Pump use on mortality in patients with cardiogenic shock treated with Primary Percutaneous Coronary Intervention: An Observational Study of 21,210 patients with ST-Elevation Myocardial Infarction from the London
    J Am Coll Cardiol. 2016;68.
    >> Share

  453. CAVALCANTE R, Sotomi Y, Suwannasom P, Lee CW, et al
    TCT-67 Impact of the SYNTAX score in patients with diabetes and left-main and/or multivessel coronary disease: a pooled analysis of individual patient level data from the SYNTAX, PRECOMBAT and BEST trials.
    J Am Coll Cardiol. 2016;68.
    >> Share

  454. ESTEVEZ R, Benito-Gonzalez T, Gualis-Cardona J, Romero-Roche L, et al
    TCT-643 Percutaneous Mitral Valve Repair for Acute Mitral Regurgitation Following an Acute Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    >> Share

  455. TERASHITA D, Morino Y, Otake H, Kikuchi T, et al
    TCT-563 Early vascular responses to everolimus-eluting cobalt-chronium stent for the treatment of ST-elevation acute myocardial infarction: the results of the MECHANISM-AMI study 3-months OCT follow-up cohort.
    J Am Coll Cardiol. 2016;68.
    >> Share

  456. OH JH, Choe JC, Ahn J, Sup PJ, et al
    TCT-558 Comparison of in-hospital outcome between intracoronary imaging-guided versus angiography-guided percutaneous coronary intervention in patient with acute myocardial infarction.
    J Am Coll Cardiol. 2016;68.
    >> Share

  457. ANTONSEN L, Christiansen E, Maeng M, Ravkilde J, et al
    TCT-551 Impact of Late Acquired Malapposition after Biolimus-eluting and Sirolimus-eluting Stent Implantation on 5-year Clinical Outcomes Following ST-segment Elevation Myocardial Infarction: Intravascular Ultrasound Analysis from the SORT OUT V Trial
    J Am Coll Cardiol. 2016;68.
    >> Share

  458. ANTONSEN L, Christiansen E, Maeng M, Ravkilde J, et al
    TCT-550 Influence of 12-month Late Incomplete Stent Apposition after Biolimus-eluting and Sirolimus-eluting Stent Implantation on 5-year Clinical Outcomes Following ST-segment Elevation Myocardial Infarction: Insigths from the SORT OUT V Trial Intrava
    J Am Coll Cardiol. 2016;68.
    >> Share

  459. SALINAS P, Mejia-Renteria H, Herrera-Nogueira R, Del Trigo M, et al
    TCT-50 Impact of a bifurcation culprit lesion in ST elevation myocardial infarction: procedural success, clinical outcome and 5-year follow-up.
    J Am Coll Cardiol. 2016;68.
    >> Share

  460. WINDECKER S, Asano T, Raber L, Brugaletta S, et al
    TCT-49 Two-year clinical outcome of Everolimus-eluting bioresorbable scaffold vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myoc
    J Am Coll Cardiol. 2016;68.
    >> Share

  461. GUAN C, Xu B, Gao R
    TCT-461 Comparison of Two Biodegradable Polymer-Based Sirolimus-Eluting Stents with Varying Elution and Absorption Kinetics in Acute Myocardial Infarction Patients: A Subgroup Analysis of PANDA III Trial.
    J Am Coll Cardiol. 2016;68.
    >> Share

  462. AL NOORYANI A, Elabbassi W, Markovic M, Bhatia A, et al
    TCT-429 Safety, feasibility and performance of the first 300 everolimus-eluting bioresorbable scaffold PCI in an all-comers population with ischemic heart disease.
    J Am Coll Cardiol. 2016;68.
    >> Share

  463. WIEBE J, Harada Y, Hoppmann P, Colleran R, et al
    TCT-414 Two-year outcomes of patients with acute coronary syndrome versus stable coronary disease undergoing bioresorbable scaffold implantation.
    J Am Coll Cardiol. 2016;68.
    >> Share

  464. TOMANIAK M, Fam JM, Felix C, Geuns RV, et al
    TCT-412 Long-term clinical outcomes after implantation of everolimus-eluting bioresorbable vascular scaffold in patients with acute myocardial infarction. 24-month clinical follow-up of the BVS STEMI First Study.
    J Am Coll Cardiol. 2016;68.
    >> Share

  465. BRUGALETTA S, Gori T, Low A, Tousek P, et al
    TCT-404 ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-year results from a propensity score matched comparison.
    J Am Coll Cardiol. 2016;68.
    >> Share

  466. KARAMASIS G, Al-Janabi F, Mohdnazri S, Jagathesan R, et al
    TCT-386 Incidence and prevention of contrast induced acute kidney injury in ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
    J Am Coll Cardiol. 2016;68.
    >> Share

  467. PATEL N, Patel N, Arora S, Alfonso C, et al
    TCT-380 Outcomes of Patients with Acute Myocardial Infarction in Moderate to Severe Chronic Kidney Disease in the United States.
    J Am Coll Cardiol. 2016;68.
    >> Share

  468. SOUZA MT, Barbosa A, Souza R, Dotta G, et al
    TCT-366 Predictors of major complications secondary to cardiac catheterization through femoral access in ST elevation in acute myocardial infarction during Pharmaco-Invasive Therapy.
    J Am Coll Cardiol. 2016;68.
    >> Share

  469. YEE J, Higgins J, Kumar V, Anuwatworn AS, et al
    TCT-363 Patient Characteristics Influencing Physician Selection of Radial vs. Femoral Access in patients presenting emergently with ST-Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    >> Share

  470. AL NOORYANI A, Elabbassi W, Markovic M, Kerfes G, et al
    TCT-356 The use of robotic-assisted PCI for the treatment of patients with ischemic heart disease.
    J Am Coll Cardiol. 2016;68.
    >> Share

  471. JIANG L, Yuan J, Gao R, Xu B, et al
    TCT-346 Impact of anemia after coronary stenting on long-term outcomes of patients with coronary disease.
    J Am Coll Cardiol. 2016;68.
    >> Share

  472. HERMANIDES R, Kedhi E, Kennedy M, van Dijk P, et al
    TCT-266 Impact of elevated glycosylated hemoglobin (HbA1c) on admission on long-term Mortality in Patients with Unknown Diabetes Mellitus Presenting with acute myocardial infarction (STEMI or NSTEMI).
    J Am Coll Cardiol. 2016;68.
    >> Share

  473. CHO MS, Kang DY, Do U, Hong JA, et al
    TCT-258 Clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention for multi-vessel coronary artery disease.
    J Am Coll Cardiol. 2016;68.
    >> Share

  474. HE Y, Li Y, Zhang D, Xu B, et al
    TCT-254 A Novel Tool for Risk Prediction of PEriprocedural MyocaRdial InFarction after PErcutaneous Coronary InTervention: the PERFECT Score System.
    J Am Coll Cardiol. 2016;68.
    >> Share

  475. KUMAR A, Wagener J, Jones S, Wojdyla D, et al
    TCT-244 Lower rates of repeat revascularization among patients with prior coronary artery bypass grafting is partly due to lack of adequate target vessels.
    J Am Coll Cardiol. 2016;68.
    >> Share

  476. JINNOUCHI H, Kuramitsu S, Ando K
    TCT-240 Long-Term Clinical Outcome of Drug-Eluting Stent Following Rotational Atherectomy for Heavily Calcified Lesions.
    J Am Coll Cardiol. 2016;68.
    >> Share

  477. CHO MS, Do U, Lee K, Hong JA, et al
    TCT-242 Temporal Changes in Outcomes after Stent or Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease by Diabetes Status.
    J Am Coll Cardiol. 2016;68.
    >> Share

  478. AMEMIYA K, Yamamoto MH, Maehara A, Oyama Y, et al
    TCT-239 Effect of Cutting Balloon after Rotablator in Severely Calcified Coronary Artery Lesions Assessed by Optical Frequency Domain Imaging.
    J Am Coll Cardiol. 2016;68.
    >> Share

  479. REDFORS B, Genereux P, Maehara A, Kirtane A, et al
    TCT-237 Outcomes After Successful PCI of Severely Calcified Lesions Using Rotational Atherectomy, Cutting Balloon, or Balloon Angioplasty only Before Second-Generation Drug-Eluting Stent Implantation.
    J Am Coll Cardiol. 2016;68.
    >> Share

  480. KARACSONYI J, Martinez-Parachini JR, Alame A, Danek BA, et al
    TCT-233 Contemporary Use of Laser during Percutaneous Coronary Intervention: Initial Results from the Laser Veterans Affairs (LAVA) Registry.
    J Am Coll Cardiol. 2016;68.
    >> Share

  481. EDES IF, Ruzsa Z, Szabo G, Lux A, et al
    TCT-228 Rotational atherectomy of malapposed, undilatable coronary stents: fact or fiction?
    J Am Coll Cardiol. 2016;68.
    >> Share

  482. MCGREW A, Singh M, Stahl J, Yoos J, et al
    TCT-230 Rotational Atherectomy vs Orbital Atherectomy in Calcified Coronary Artery Disease: A Contemporary Retrospective Comparative Analysis (ROCC study).
    J Am Coll Cardiol. 2016;68.
    >> Share

  483. BURGOS JM, Gonzalez BS, Canton T, Lazaro-Fernandez E, et al
    TCT-226 Thrombus Aspiration for OcLuded Coronary Artery Enhanced With Distal Injection Of Abciximab (TOLEDO 1).
    J Am Coll Cardiol. 2016;68.
    >> Share

  484. KADRO W, Muhanna J, Turkmani M, Rumman R, et al
    TCT-225 Cliopidogril And Ticagrelor Highlights on Silent Holter Ambulatory Myocardial Ischemia (CATH SHAMI study).
    J Am Coll Cardiol. 2016;68.
    >> Share

  485. FAGGIONI M, Chandrasekhar J, Aquino M, Vogel B, et al
    TCT-224 Real world use of antithrombotic regimens after percutaneous coronary intervention in patients with atrial fibrillation.
    J Am Coll Cardiol. 2016;68.
    >> Share

  486. LEE CH, Kwon O, Do U, Hong JA, et al
    TCT-223 A randomized, placebo controlled, double-blind, phase 4 study to evaluate efficacy and safety of triple anti-platelet therapy compared with dual antiplatelet therapy in patients treated with drug-eluting stent for coronary artery disease.
    J Am Coll Cardiol. 2016;68.
    >> Share

  487. HWANG D, Lee JM, Rhee TM, Park J, et al
    TCT-222 Clinical Outcomes of Dual Antiplatelet Therapy after Coronary Stenting in Patients with Chronic Kidney Disease: Patient-level Meta-analysis of 4 Randomized Clinical Trials.
    J Am Coll Cardiol. 2016;68.
    >> Share

  488. FARHAN S, Baber U, Chandrasekhar J, Sartori S, et al
    TCT-221 Predictors of optimal medical therapy on discharge after percutaneous coronary intervention for acute coronary syndrome: An analysis of the PROMETHEUS registry.
    J Am Coll Cardiol. 2016;68.
    >> Share

  489. FAGGIONI M, Chandrasekhar J, Baber U, Vogel B, et al
    TCT-219 Influence Of Anemia On Physician-Recommended DAPT Discontinuation After Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    >> Share

  490. ROSSINGTON J, Hoye A, Spurgeon B, Aznaouridis K, et al
    TCT-220 Is Inhibition of Platelet Aggregation by Endogenous Endothelial Platelet Antagonists Enhanced by Oral Ticagrelor Mediated P2Y12 Blockade in Patients With Coronary Artery Disease?
    J Am Coll Cardiol. 2016;68.
    >> Share

  491. MAHMOUD A, Elgendy I
    TCT-218 Factors influencing the risk of major bleeding with bivalirudin compared with unfractionated heparin in percutaneous coronary intervention.
    J Am Coll Cardiol. 2016;68.
    >> Share

  492. MAHMOUD A, Elgendy I
    TCT-215 Meta-analysis of randomized trials comparing bivalirudin versus unfractionated heparin for percutaneous coronary intervention through trans-radial approach.
    J Am Coll Cardiol. 2016;68.
    >> Share

  493. LAU J, Alcock R, Cherry J, Yong A, et al
    TCT-212 Application of the DAPT score to a contemporary Percutaneous Coronary Intervention cohort.
    J Am Coll Cardiol. 2016;68.
    >> Share

  494. GIUSTINO G, Chieffo A, Palmerini T, Valgimigli M, et al
    TCT-213 Efficacy and Safety of Long- Versus Short-Term Dual Antiplatelet Therapy Following Complex Percutaneous Coronary Intervention with Drug-Eluting Stents: A Collaborative Patient-Level Pooled Analysis of Randomized Controlled Trials.
    J Am Coll Cardiol. 2016;68.
    >> Share

  495. SAAD M, Gamal A, Nairooz R
    TCT-210 Bivalirudin versus Heparin in Women undergoing Percutaneous Coronary Intervention: A Meta-analysis of Randomized Clinical Trials.
    J Am Coll Cardiol. 2016;68.
    >> Share

  496. MURANISHI H, Yamaji K, Yamaji Y, Ando K, et al
    TCT-209 Optimal duration of dual antiplatelet therapy after left main coronary artery stenting: A retrospective multicenter AOI LMCA stenting registry.
    J Am Coll Cardiol. 2016;68.
    >> Share

  497. HARADA Y, Lohaus R, Mayer K, Emmer R, et al
    TCT-207 Extended validation of a decision tool (DAPT score) in patients randomized to 6 or 12 months dual antiplatelet therapy after percutaneous coronary intervention with predominantly second-generation drug-eluting stents.
    J Am Coll Cardiol. 2016;68.
    >> Share

  498. FERRI LA, Chieffo A, Giustino G, Frasheri A, et al
    TCT-204 Optimal duration of dual antiplatelet therapy (DAPT) after second generation drug-eluting stent (DES) implantation in elderly patients: the SECURITY-ELDERLY substudy.
    J Am Coll Cardiol. 2016;68.
    >> Share

  499. PHILIP F, Anderson S, Ram S, Bommer W, et al
    TCT-202 Interaction between choice of anticoagulation, antiplatelet therapy and access site on mortality and bleeding after percutaneous coronary intervention: Insights from the California NCDR registry.
    J Am Coll Cardiol. 2016;68.
    >> Share

  500. ANANTHA NARAYANAN M, Gujjula N, Anugula D, Reddy YN, et al
    TCT-203 Dual versus triple anti thrombotic therapy in Acute Coronary Syndromes - A meta analysis.
    J Am Coll Cardiol. 2016;68.
    >> Share

  501. EMBACHER M, Kosmidou I, Dordi R, Redfors B, et al
    TCT-200 Correlation of Admission Heart Rate With Angiographic and Clinical Outcomes by Culprit Coronary Artery in Patients With STEMI Undergoing Primary PCI: The HORIZONS-AMI Trial.
    J Am Coll Cardiol. 2016;68.
    >> Share

  502. ROBERTS L, Parfrey S, Andrianopoulos N, Teh A, et al
    TCT-187 Safety of Early Discharge Following Percutaneous Coronary Intervention (PCI) for STEMI.
    J Am Coll Cardiol. 2016;68.
    >> Share

  503. HAHN JY, Kim EK, Park TK, Lee JM, et al
    TCT-171 Effect of Ticagrelor Compared with Clopidogrel on Myocardial Infarct Size in Patients Undergoing Primary Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    >> Share

  504. NARAYANAN MA, Reddy YN, Anugula D, Gujjula N, et al
    TCT-156 Bivalirudin versus Heparin in Primary Percutaneous Coronary Intervention- a Meta analysis.
    J Am Coll Cardiol. 2016;68.
    >> Share

  505. CID ALVAREZ AB, Redondo Dieguez A, Galvao Braga C, Trillo R, et al
    TCT-149 Impact of Chronic Total Occlusion in a Non-Infarct-related Artery on clinical outcomes in patients undergoing Primary Percutanous Coronary Intervention: analysis of a 8 year-all-comers prospective registry.
    J Am Coll Cardiol. 2016;68.
    >> Share

  506. AZZALINI L, Dautov R, Ojeda S, Bellini B, et al
    TCT-13 Outcomes of chronic total occlusion percutaneous coronary intervention according to dissection/re-entry versus wire escalation techniques.
    J Am Coll Cardiol. 2016;68.
    >> Share

  507. JONES D, Rathod K, Weerackody R, Wragg A, et al
    TCT-14 Specialist Chronic Total Occlusion (CTO) Programmes and Outcomes after CTO Percutaneous Coronary Interventions: An observational study of 5,496 patients from the Pan-London CTO Cohort.
    J Am Coll Cardiol. 2016;68.
    >> Share

  508. DANEK BA, Karatasakis A, Karmpaliotis D, Alaswad K, et al
    TCT-15 Use of Antegrade Dissection Re-entry in Coronary Chronic Total Occlusion Percutaneous Coronary Intervention in a Contemporary Multicenter Registry.
    J Am Coll Cardiol. 2016;68.
    >> Share

  509. KOIFMAN E, Garcia-Garcia HM, Kiramijyan S, Negi S, et al
    TCT-144 Impact of Thrombus Aspiration in Primary Percutaneous Coronary Intervention On Long-Term Outcome.
    J Am Coll Cardiol. 2016;68.
    >> Share

  510. VOUDRIS K, Vidovich M
    TCT-142 Temporal Trends in Incidence of Acute Myocardiacl Infarction in Patients With Malignancy Undergoing Percutaneous Coronary Intervention (PCI).
    J Am Coll Cardiol. 2016;68.
    >> Share

  511. SHAVELLE D, Kapasi N, Banerjee S, Schreiber T, et al
    TCT-127 Prior Coronary Artery Bypass Graft Surgery and Hemodynamically Supported High Risk Percutaneous Coronary Intervention: Observations from The PROTECT II Randomized Trial and The cVAD Registry.
    J Am Coll Cardiol. 2016;68.
    >> Share

  512. SHARMA S, Palacios I, O'Neill W, Witzke CF, et al
    TCT-124 Predictors of the Need for Continuous Impella Support in High Risk Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    >> Share

  513. FLAHERTY M, Pant S, Kilgore T, Dassanayaka S, et al
    TCT-123 Impella 2.5 Support Protects Against Acute Kidney Injury in Patients Undergoing High-Risk Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    >> Share

  514. PATEL N, Patel N, Arora S, Badheka A, et al
    TCT-118 Sex Differences in Coronary Angiography, Percutaneous Coronary Intervention, and Outcomes During Hospitalization After Out of Hospital Cardiac Arrest with Ventricular Fibrillation or Pulseless Ventricular Tachycardia.
    J Am Coll Cardiol. 2016;68.
    >> Share

  515. ANSARI M, Garcia D
    TCT-116 Elective Use of Intra-Aortic Balloon Pump For High-Risk Percutaneous Coronary Intervention For ACS: Meta-Analysis of RCT's.
    J Am Coll Cardiol. 2016;68.
    >> Share

  516. CHO S, Cho GY, Kim D, Lim SH, et al
    TCT-115 Clinical features and Outcomes in patients with Acute Coronary Syndrome Complicated by Cardiogenic Shock supported with Extracorporeal Membrane Oxygenation, Single Center Experience.
    J Am Coll Cardiol. 2016;68.
    >> Share

  517. CHANDRASEKHAR J, Baber U, Sartori S, Aquino M, et al
    TCT-111 Relationship between anemia, prasugrel use and clinical outcomes in contemporary percutaneous coronary intervention for acute coronary syndromes.
    J Am Coll Cardiol. 2016;68.
    >> Share

  518. REDFORS B, Volz S, Angeras O, Haraldsson I, et al
    TCT-107 Ticagelor is not superior to clopidogrel in patients with acute coronary syndrome - A report from SCAAR.
    J Am Coll Cardiol. 2016;68.
    >> Share

  519. GARCIA E, Hong S, Cho SA, Cho JY, et al
    TCT-108 Comparison of Ticagrelor versus Prasugrel on Inflammation, Vascular Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients with Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting: Prospective,
    J Am Coll Cardiol. 2016;68.
    >> Share

  520. RAFIQUE A, Chandrasekhar J, Baber U, Sartori S, et al
    TCT-105 Prevalence of prasugrel use and associations between type of acute coronary syndrome and 1-year clinical outcomes.
    J Am Coll Cardiol. 2016;68.
    >> Share

  521. FALLESEN CO, Christiansen E, Botker HE, Raungaard B, et al
    TCT-106 Outcomes after Revascularization with Sirolimus-eluting and Birolimus-Eluting Stents with biodegradable polymer In Patients with Acute Coronary Syndromes. From the SORT OUT VII Trial.
    J Am Coll Cardiol. 2016;68.
    >> Share

  522. SHAH R, Hwang IH, Nayyar M, Slomka T, et al
    TCT-104 Relative Efficacy and Safety of oral P2Y12 inhibitors in Acute coronary syndrome: An Updated Network Meta-Analysis of Randomized Trials.
    J Am Coll Cardiol. 2016;68.
    >> Share

  523. PRAKASH R, Starovoytov A, Aymong E, Saw J, et al
    TCT-103 Angiographic Healing of Spontaneous Coronary Artery Dissection.
    J Am Coll Cardiol. 2016;68.
    >> Share

  524. YONG C, Abnousi F, Asch S, Heidenreich P, et al
    TCT-100 Asians suffer the highest in-hospital mortality rates after acute coronary syndrome despite high use of early invasive procedures.
    J Am Coll Cardiol. 2016;68.
    >> Share

  525. SHAH R, Hwang IH, Nayyar M, Christian E, et al
    TCT-102 Association Between Operator Experience with Access Type in Percutaneous Coronary Intervention and Outcomes in Patients with Acute Coronary Syndrome: A Network Meta-Analysis of Randomized Controlled Trials.
    J Am Coll Cardiol. 2016;68.
    >> Share

  526. SAW J, Starovoytov A, Zhao Y, Peng D, et al
    TCT-101 Predictors for Recurrent Dissection after Spontaneous Coronary Artery Dissection.
    J Am Coll Cardiol. 2016;68.
    >> Share

  527. WESTRA J, Tu S, Nissen L, Winther S, et al
    TCT-10 Physiological testing of coronary artery stenosis by computation of invasive coronary angiography. The wire-free functional imaging (WIFI-II) study.
    J Am Coll Cardiol. 2016;68.
    >> Share

  528. KOVARNIK T, Chen Z, Wahle A, Fukumoto Y, et al
    TCT-96 Progression of coronary atherosclerosis despite lipid-lowering therapy in diabetic patients compared to non-dibetic ones. Study with 3D intravascular ultrasound and virtual histology.
    J Am Coll Cardiol. 2016;68.
    >> Share

  529. UMMAN S, Umman B, Aslanger E, Atici A, et al
    TCT-95 The interplay between features of plaque vulnerability and hemodynamic relevance of coronary artery stenoses.
    J Am Coll Cardiol. 2016;68.
    >> Share

  530. SCHUURMAN AS, Kardys I, Oemrawsingh R, Diletti R, et al
    TCT-93 Near-infrared spectroscopy derived Lipid Core Burden Index predicts major adverse cardiovascular events in patients with coronary artery disease during 4.3 year follow-up.
    J Am Coll Cardiol. 2016;68.
    >> Share

  531. KHARLAMOV A
    TCT-854 Cardiovascular Burden and Percutaneous Interventions in Russia: Epidemiological Update and Results of National Screening.
    J Am Coll Cardiol. 2016;68.
    >> Share

  532. LACOMBE A, O'Brien A, Bundy J, Clarey A, et al
    TCT-852 Impact of Robotics and a Suspended Lead Suit on Physician Radiation Exposure During Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    >> Share

  533. TELLEZ A, Gasior P, Shanmuganayagam D, Conditt G, et al
    TCT-841 Combined Coronary Artery Imaging for Plaque Characterization in Preclinical Studies: An OCT-IVUS-Histological Study of the Familial Hypercholesterolemic Swine Model.
    J Am Coll Cardiol. 2016;68.
    >> Share

  534. BUSZMAN P, Michalak M, Pruski M Jr, Jelonek M, et al
    TCT-837 Comparable vascular response of a new generation sirolimus eluting stents when compared to fluoropolymer everolimus eluting stents in the porcine coronary restenosis model.
    J Am Coll Cardiol. 2016;68.
    >> Share

  535. YAHAGI K, Kolodgie F, Cheng D, Acampado E, et al
    TCT-836 Endothelial Cell Coverage and Inflammation Comparing COBRA Polyzene-F (PzF) Coated Stent to Durable Fluoropolymer and Biodegradable Polymer Drug-Eluting Stents in a Rabbit Model.
    J Am Coll Cardiol. 2016;68.
    >> Share

  536. SCHIAVONE A, Abunassar C, Zhao L, Hossainy S, et al
    TCT-834 Bioresorbable Scaffolds versus Metallic Drug Eluting Stents - Comparison of Predicted Arterial Stress after Simulated Deployment in Concentric and Eccentric Coronary Lesions.
    J Am Coll Cardiol. 2016;68.
    >> Share

  537. YAHAGI K, Kolodgie F, Cheng D, Acampado E, et al
    TCT-835 Endothelial Function Assessed by Expression of Adherens Junctions and Inflammation between Durable and Biodegradable Polymer Drug-Eluting Stents in the Rabbit Iliofemoral Model.
    J Am Coll Cardiol. 2016;68.
    >> Share

  538. VALENCIA A, Gasior P, Cheng Y, Xia J, et al
    TCT-832 In Vivo Biomechanical Performance of Thin Strut Sirolimus-Eluting Coronary Scaffold, Regular-Strut Scaffolds and Bare Metal Stents in Normal Porcine Coronary Arteries.
    J Am Coll Cardiol. 2016;68.
    >> Share

  539. VALENCIA A, Gasior P, Cheng Y, Xia J, et al
    TCT-831 Novel Thin Strut (100 mum) Ultra-High Molecular Weight PLLA Sirolimus-Eluting Bioresorbable Scaffold: A Comparative Preclinical Evaluation in Porcine Coronary Arteries.
    J Am Coll Cardiol. 2016;68.
    >> Share

  540. GASIOR P, Cheng Y, Xia J, Valencia A, et al
    TCT-829 Biomechanical Behavior and Healing Response of a Novel Thin Strut Sirolimus Eluting Bioresorbable Scaffold Overexpanded up to 0.75 mm Beyond Nominal Compliance Chart Diameters in Porcine Coronary Artery Model.
    J Am Coll Cardiol. 2016;68.
    >> Share

  541. GOGAS BD, Kumar S, Benham J, Panchal D, et al
    TCT-828 Very Late Vasomotor Responses and Gene Expression Profiles of Porcine Coronary Arteries at 4 Years after Deployment of the Everolimus-eluting Bioresorbable Vascular Scaffold and the Everolimus-eluting Metallic Xience V stent.
    J Am Coll Cardiol. 2016;68.
    >> Share

  542. CHAKRAVARTY T, Makkar R, Henry T, Kittleson M, et al
    TCT-820 Multivessel Intracoronary Infusion of Allogeneic Cardiosphere Derived Cells in Dilated Cardiomyopathy: Long Term Outcomes of the Dilated Cardiomyopathy Intervention with Allogeneic Myocardially-Regenerative Cells (DYNAMIC Trial).
    J Am Coll Cardiol. 2016;68.
    >> Share

  543. GHIRARDI G, Ferrari C, Pontone G, Trabattoni D, et al
    TCT-809 Stenting for the treatment of pulmonary vein stenosis after atrial fibrillation radiofrequency catheter ablation: initial experience with peripheral stents plus drug-coated balloons and coronary drug-eluting stents.
    J Am Coll Cardiol. 2016;68.
    >> Share

  544. ISHIHARA T, Iida O, Kozuki A, Shinke T, et al
    TCT-785 Association between the Platelet Reactivity under Clopidogrel Treatment and the Severity of Angioscopic Intra-stent Thrombus Following Drug-eluting Stent Implantation in the Femoropopliteal Artery.
    J Am Coll Cardiol. 2016;68.
    >> Share

  545. GASIOR P, Cheng Y, Valencia A, McGregor J, et al
    TCT-776 Vascular Healing Response after Implantation of a Novel Fluoropolymer-Coated Paclitaxel-Eluting Peripheral Stent: a Comparative Drug-Eluting Stent Study in a Familial Hypercholesterolemic Swine Model of Balloon-Injured Femoral Arteries.
    J Am Coll Cardiol. 2016;68.
    >> Share

  546. YOON HJ, Oh JH, Kim KB, Bae HJ, et al
    TCT-76 Temporal change of in-stent thrombus immediately after percutaneous coronary intervention within 5 minutes using optical coherence tomography.
    J Am Coll Cardiol. 2016;68.
    >> Share

  547. CHETCUTI S, Kleiman N, Matthews R, Popma J, et al
    TCT-743 Percutaneous Coronary Intervention after Self-Expanding Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2016;68.
    >> Share

  548. YAMAMOTO MH, Yamashita K, Matsumura M, Ebara S, et al
    TCT-73 Serial Three-Vessel Optical Coherence Tomography and Intravascular Ultrasound Analysis of Changing Morphologies Associated of Plaque Progression in Patients With Stable Angina Pectoris.
    J Am Coll Cardiol. 2016;68.
    >> Share

  549. SMITS P, Ben-Yehuda O, Kosmidou I, Ozan MO, et al
    TCT-71 The NIREUS Randomized Trial: 1-Year Results of the BioNIR Ridaforolimus-Eluting Coronary Stent System (BioNIR) EUropean Angiography Study.
    J Am Coll Cardiol. 2016;68.
    >> Share

  550. GOMEZ MENCHERO A, Balaguer J, Lopez Otero D, Piris RM, et al
    TCT-72 Short and medium-term clinical outcome of amphilimus polymer-free drug-eluting stent in diabetic patients: An all-comers multicenter spanish registry. (Control-8 registry).
    J Am Coll Cardiol. 2016;68.
    >> Share

  551. WONG SC, Voudris K, Bergman G, Minutello R, et al
    TCT-709 Trans-apical Transcatheter Aortic Valve Replacement in Patients with History of Coronary Artery Bypass Grafting: An Analysis from the National Inpatient Sample Database.
    J Am Coll Cardiol. 2016;68.
    >> Share

  552. SINGH V, Thakkar B, Rodriguez A, Patel N, et al
    TCT-697 Comparison of Outcomes of Transcatheter Aortic Valve Replacement plus Percutaneous Coronary Intervention versus Transcatheter Aortic Valve Replacement Alone in the United States.
    J Am Coll Cardiol. 2016;68.
    >> Share

  553. PATEL N, Patel N, Arora S, Singh V, et al
    TCT-680 Impact of Annual Hospital Percutaneous Coronary Intervention Volume on Transcatheter Aortic-Valve Replacement Outcomes.
    J Am Coll Cardiol. 2016;68.
    >> Share

  554. CHANDRASEKHAR J, Redfors B, Genereux P, Kirtane A, et al
    TCT-65 Comparative Efficacy and Safety of Coronary Stents in Diabetic Patients With and Without Insulin Treatment: A pooled patient level analysis from 17 randomized trials.
    J Am Coll Cardiol. 2016;68.
    >> Share

  555. ZBRONSKI K, Huczek Z, Grodecki K, Kochman J, et al
    TCT-651 Impact of preprocedural coronary artery disease assessed by SYNTAX score on TAVI outcome.
    J Am Coll Cardiol. 2016;68.
    >> Share

  556. VEMULAPALLI S, Lippmann SJ, Krucoff M, Hernandez A, et al
    TCT-645 Cardiovascular Events and Hospital Resource Utilization Pre and Post Transcatheter Mitral Valve Repair in High Surgical Risk Patients.
    J Am Coll Cardiol. 2016;68.
    >> Share

  557. AZZALINI L, Dautov R, Ojeda S, Bellini B, et al
    TCT-64 Percutaneous coronary intervention for in-stent chronic total occlusion: procedural and long-term outcomes.
    J Am Coll Cardiol. 2016;68.
    >> Share

  558. ISHIHARA S, Muramatsu T, Kashima Y, Okamura A, et al
    TCT-62 Outcomes of re-attempt percutaneous coronary intervention for chronic total occlusion: 2-year data from Retrograde Summit Registry.
    J Am Coll Cardiol. 2016;68.
    >> Share

  559. STONE G, Abraham W, Lindenfeld J, Weissman N, et al
    TCT-627 Cardiovascular Outcomes Assessment of MitraClip Therapy in Heart Failure Patients with Functional Mitral Regurgitation (The COAPT Trial): Baseline Characteristics and Preliminary 30-Day and 1-Year Outcomes of the Roll-In Cohort.
    J Am Coll Cardiol. 2016;68.
    >> Share

  560. LEE SH, Cho JY, Joo HJ, Park JH, et al
    TCT-620 A comparison of clinical outcomes between triple antithrombotic therapy versus dual antiplatelet with left atrial appendage occlusion in patients with atrial fibrillation undergoing drug-eluting stent implantation.
    J Am Coll Cardiol. 2016;68.
    >> Share

  561. MASHAYEKHI K, Toma A, Behnes M, Gick M, et al
    TCT-61 Long-term Outcomes of Patients with Left Ventricular Dysfunction Undergoing Percutaneous Coronary Intervention for Chronic Total Occlusion.
    J Am Coll Cardiol. 2016;68.
    >> Share

  562. SHAH A, Bach Y, Osten M, Benson L, et al
    TCT-607 Trans-catheter closure of coronary artery fistulae in adult patients & long-term outcomes: A single centre experience.
    J Am Coll Cardiol. 2016;68.
    >> Share

  563. DRIESEN B, Voskuil M, Sieswerda G, Schoof P, et al
    TCT-606 Can we justify conservative treatment in adults with Anomalous Coronary Artery Originating from the Opposite Sinus of Valsalva (ACAOS) with inter-arterial course (IAC)?
    J Am Coll Cardiol. 2016;68.
    >> Share

  564. WEST N, Owen R, Hoole S, Brown A, et al
    TCT-602 Identification of local translesional intracoronary gradients of inflammatory biomolecules during PCI procedures using a novel dedicated sampling catheter.
    J Am Coll Cardiol. 2016;68.
    >> Share

  565. COSTOPOULOS C, Huang Y, Brown A, Calvert P, et al
    TCT-598 Plaque rupture in coronary atherosclerosis is associated with increased plaque structural stress.
    J Am Coll Cardiol. 2016;68.
    >> Share

  566. TOBA T, Choi G, Uzu K, Shinke T, et al
    TCT-597 Why does thin-cap fibroatheroma cluster in the proximal segment in left anterior coronary artery, but are evenly distributed throughout the entire right coronary artery? Results from computational fluid dynamics simulation by CT-FFR.
    J Am Coll Cardiol. 2016;68.
    >> Share

  567. OTA H, Tanigaki T, Okamoto S, Omori H, et al
    TCT-593 The Impact of Coronary Plaque Composition on Fractional Flow Reserve Improvement after Percutaneous Coronary Intervention: An Integrated-backscatter Intravascular Ultrasound Study.
    J Am Coll Cardiol. 2016;68.
    >> Share

  568. AGASTHI P, Aloor S, Menon V, Lee K, et al
    TCT-594 Difference in Neointimal Coverage between First Generation versus Second Generation Drug Eluting Stents using Optical Coherence tomography: A Meta-Analysis.
    J Am Coll Cardiol. 2016;68.
    >> Share

  569. SABBAH M, Kadota K, Eraki A, Kamal H, et al
    TCT-596 In-Stent Neoatherosclerosis and Tissue Characteristics of Restenotic Lesions Following Implantation of Second Generation Drug-Eluting Stents in Unrestricted Coronary Lesions: Optical Frequency Domain Imaging study.
    J Am Coll Cardiol. 2016;68.
    >> Share

  570. JINNOUCHI H, Kuramitsu S, Domei T, Ando K, et al
    TCT-592 Difference of Tissue Characteristics between Early and Late Restenosis after Implanting Second-Generation Drug-Eluting Stents Assessed by Optical Coherence Tomography.
    J Am Coll Cardiol. 2016;68.
    >> Share

  571. TSUKIYAMA Y, Kozuki A, Shinke T, Otake H, et al
    TCT-590 Potent effect of prasugrel on acute phase resolution of intra-stent tissue after percutaneous intervention to acute coronary syndrome.
    J Am Coll Cardiol. 2016;68.
    >> Share

  572. HASHIMOTO S, Takahashi A, Yamada T, Mizuguchi Y, et al
    TCT-589 Effectiveness of Excimer Laser Coronary Angioplasty with Optical Coherence Tomography Guidance for In-stent Restenosis after Drug Eluting Stent Implantation.
    J Am Coll Cardiol. 2016;68.
    >> Share

  573. CAMACHO FREIRE SJ, Menchero AG, Jimenez JL, Piris R, et al
    TCT-586 Utility of intracoronary imaging techniques in the characterisation of substrates causing acute coronary syndrome in normal o near normal coronary angiography (NONCA).
    J Am Coll Cardiol. 2016;68.
    >> Share

  574. KIM YH, Rha SW, Her AY, Choi BG, et al
    TCT-584 Is there Benefit in Intravascular Ultrasound-guided Stenting in Simple Left Main Disease?
    J Am Coll Cardiol. 2016;68.
    >> Share

  575. VERMA K, Cheshire C, Nerlekar N, McCormick L, et al
    TCT-577 Intravascular ultrasound guidance during percutaneous coronary intervention using second-generation drug-eluting stents improves clinical outcomes and reduces restenosis rates: a comparative 8,265 patient meta-analysis.
    J Am Coll Cardiol. 2016;68.
    >> Share

  576. ZHANG W, Mintz G, Cao Y, Matsumura M, et al
    TCT-576 Clinical Determinants of Plaque Morphology in Coronary Artery Disease: An OCT and IVUS Co-Registered Study.
    J Am Coll Cardiol. 2016;68.
    >> Share

  577. KARACSONYI J, Alaswad K, Jaffer F, Yeh R, et al
    TCT-572 Use of Intravascular Imaging During Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from a Contemporary Multicenter Registry.
    J Am Coll Cardiol. 2016;68.
    >> Share

  578. REDFORS B, Genereux P, Kirtane A, Pocock S, et al
    TCT-55 Risk-Benefit Analysis of Upstream Antithrombotic Therapy in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes Prior to Coronary Angiography.
    J Am Coll Cardiol. 2016;68.
    >> Share

  579. SONODA S, Sanuki Y, Muraoka Y, Takami H, et al
    TCT-565 Fate of irregular protrusion after second-generation drug-eluting stent implantation: Serial optical coherence tomography study.
    J Am Coll Cardiol. 2016;68.
    >> Share

  580. SHIN DH, Hong SJ, Mintz G, Kim JS, et al
    TCT-564 Effect of Intravascular Ultrasound-Guided vs. Angiography-Guided New-Generation Drug-Eluting Stent Implantation; Meta-analysis with Individual Patient-Level Data from 2,345 Randomized Patients.
    J Am Coll Cardiol. 2016;68.
    >> Share

  581. SAITO Y, Kitahara H, Nakayama T, Fujimoto Y, et al
    TCT-560 Novel Predictor of Target Vessel Revascularization after Coronary Stent Implantation: Intraluminal Intensity of Blood Speckle on Intravascular Ultrasound.
    J Am Coll Cardiol. 2016;68.
    >> Share

  582. LEE SH, Cho JY, Joo HJ, Park JH, et al
    TCT-559 Optical coherence tomography (OCT) guided percutaneous coronary intervention : clinical impact of acute abnormal findings after drug-eluting stent implantation detected only by OCT.
    J Am Coll Cardiol. 2016;68.
    >> Share

  583. SHI B, Liu Z, Deng C, Deng W, et al
    TCT-556 Research and clinical applications of potical coherence tomography in 25 cases of the drug-eluting stents implantated patients with in-stent restenosis.
    J Am Coll Cardiol. 2016;68.
    >> Share

  584. TANG Y, Tian J, Guan C, Wang W, et al
    TCT-555 Intravascular Ultrasound Guidance Improves the Long-term Prognosis in Patients with Unprotected Left Main Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    >> Share

  585. WEBER J, Kassis N, Shah K, Lopez J, et al
    TCT-553 An Optical Coherence Tomography Comparison of Coronary Arterial Plaque Calcification in a Matched Cohort of Patients With and Without End-Stage Renal Disease and Diabetes Mellitus.
    J Am Coll Cardiol. 2016;68.
    >> Share

  586. ROMAGNOLI E, Gatto L, La Manna A, Burzotta F, et al
    TCT-549 ROLE of RESIDUAL ACUTE STENT MALAPPOSITION in percutaneous coronary interventions: a CLI-OPCI project SUBSTUDY.
    J Am Coll Cardiol. 2016;68.
    >> Share

  587. DEGRELL P, Adjedj J, Aoumeur H, Navarro A, et al
    TCT-545 Use of optical coherence tomography to detect acute coronary syndrome in survivors of out-of-hospital cardiac arrest without ST-segment elevation on ECG.
    J Am Coll Cardiol. 2016;68.
    >> Share

  588. ALI Z, Galougahi KK, Nazif T, Maehara A, et al
    TCT-546 Imaging and physiology-guided zero contrast percutaneous coronary intervention in advanced chronic kidney disease.
    J Am Coll Cardiol. 2016;68.
    >> Share

  589. PATEL J, Lau E, Kurtz S, Savage M, et al
    TCT-544 Fractional Flow Reserve Utilization in Patients with Stable Coronary Artery Disease.
    J Am Coll Cardiol. 2016;68.
    >> Share

  590. LIOU K, Jepson N, Kushwaha V, Yu J, et al
    TCT-543 Calculation of Serial Index of Microvascular Resistance with Adjusted Wedge Pressure in Patients with Non-ST Elevation Acute Coronary Syndrome.
    J Am Coll Cardiol. 2016;68.
    >> Share

  591. MATSUSHITA K, Hibi K, Okada K, Matsuzawa Y, et al
    TCT-539 Comparison between Instantaneous Wave-Free Ratio and Fractional Flow Reserve versus Morphometric Assessments by Intracoronary Imaging Devices.
    J Am Coll Cardiol. 2016;68.
    >> Share

  592. VAN NUNEN L, Hennigan B, Veer MV
    TCT-541 Different performance of iFR in the right and left coronary artery.
    J Am Coll Cardiol. 2016;68.
    >> Share

  593. GURUNATHAN S, Young G, Karogiannis N, Elghamaz A, et al
    TCT-540 Diagnostic Accuracy of Stress Echocardiography Compared With Invasive Coronary Angiography With Fractional Flow Reserve for the Diagnosis of Haemodynamically Significant Stenosis(Es) in Patients With Known or Suspected Coronary Artery Disease.
    J Am Coll Cardiol. 2016;68.
    >> Share

  594. VAN BOMMEL R, Lemmert M, Wang Y, Daemen J, et al
    TCT-536 Routine Fractional Flow Reserve Measurement after Percutaneous Coronary Intervention with a Novel FFR Micro Catheter, Insights from the FFR-SEARCH Registry - FFR Stent Evaluated at Rotterdam Cardiology Hospital.
    J Am Coll Cardiol. 2016;68.
    >> Share

  595. ZIMMERMANN F, Pijls N, De Bruyne B, Bech JW, et al
    TCT-537 What can intracoronary pressure measurements tell us about flow reserve? Pressure-bounded CFR and its application to the randomized DEFER trial.
    J Am Coll Cardiol. 2016;68.
    >> Share

  596. AHN JM, Cho MS, Kang SH, Park DW, et al
    TCT-534 Fractional Flow Reserve and Cardiac Events In Coronary Artery Disease: Data From Prospective Registry.
    J Am Coll Cardiol. 2016;68.
    >> Share

  597. AHN JM, Kang SH, Kim TH, Zimmermann F, et al
    TCT-533 Fractional Flow Reserve And Coronary Flow Reserve To Predict Outcomes in Coronary Artery Disease.
    J Am Coll Cardiol. 2016;68.
    >> Share

  598. KOGAME N, Iijima R, Hara H, Anzai H, et al
    TCT-532 Morphometric assessment of hemodynamically severe coronary stenosis relevance with optical frequency domain imaging according to vessel diameter.
    J Am Coll Cardiol. 2016;68.
    >> Share

  599. RIGATTIERI S, Biondi-Zoccai G, Sciahbasi A, Di RUsso C, et al
    TCT-531 INTRACORONARY VS. INTRAVENOUS ADENOSINE FOR FRACTIONAL FLOW RESERVE MEASUREMENT: A META-ANALYSIS.
    J Am Coll Cardiol. 2016;68.
    >> Share

  600. CALMAC L, Niculescu R, Badila E, Weiss E, et al
    TCT-527 A data-driven approach combining image-based anatomical features and resting state measurements for the functional assessment of coronary artery disease.
    J Am Coll Cardiol. 2016;68.
    >> Share

  601. DE WAARD G, Nijjer S, van Lavieren M, van der Hoeven N, et al
    TCT-524 Invasive minimal Microvascular Resistance (mMR); a new index to assess microcirculatory dysfunction that is not modulated by the presence of angiographic coronary artery disease.
    J Am Coll Cardiol. 2016;68.
    >> Share

  602. KOBAYASHI Y, Lee JM, Fearon W, Lee J, et al
    TCT-522 The Independence of Coronary Microvascular Dysfunction from Epicardial Disease Severity: Three-Vessel Invasive Coronary Physiologic Study.
    J Am Coll Cardiol. 2016;68.
    >> Share

  603. SAINSOUS J, Fajadet J, Carrie D, Elhadad S, et al
    TCT-51 In hospital and one month outcomes of 983 patients implanted with bioresorbable vascular scaffolds for Acute Coronary Syndroms; subgroup of the prospective, all comers, controlled, multicenter, FRANCE ABSORB Registry.
    J Am Coll Cardiol. 2016;68.
    >> Share

  604. KUBO S, Kuwayama A, Shimada T, Miura K, et al
    TCT-52 Proportion and Morphological Features of Restenosis Lesions with Acute Coronary Syndrome in Different Timings of Target Lesion Revascularization after Sirolimus-Eluting Stent Implantation.
    J Am Coll Cardiol. 2016;68.
    >> Share

  605. PESARINI G, Scarsini R, Zivelonghi C, Piccoli A, et al
    TCT-517 Fractional flow reserve assessment of coronary artery disease in patients Undergoing TAVI.
    J Am Coll Cardiol. 2016;68.
    >> Share

  606. OKURA H, Kobayashi Y, Neishi Y, Higa T, et al
    TCT-518 The Interaction between Aortic and Coronary Pressures for Fractional Flow Reserve Value in Patients with an Intermediate Coronary Artery Stenosis.
    J Am Coll Cardiol. 2016;68.
    >> Share

  607. KIM HY, Doh JH, Lim HS, Yoon MH, et al
    TCT-514 Comparison of angiographic scores and fractional myocardial mass: Use of fractional myocardial mass for comprehensive evaluation of coronary artery disease.
    J Am Coll Cardiol. 2016;68.
    >> Share

  608. KWON SU
    TCT-508 The PREDICT (Prognostic Role of coronary artery plaquEs in patients with suspected coronary artery Disease using multislice Computed Tomography) observational comparative outcomes study.
    J Am Coll Cardiol. 2016;68.
    >> Share

  609. WOLNY R, Pregowski J, Kruk M, Kepka C, et al
    TCT-507 Computed Tomography Angiography Versus Angiography for Guiding Percutaneous Coronary Interventions in Bifurcation Lesions - Prospective Randomized Pilot Study.
    J Am Coll Cardiol. 2016;68.
    >> Share

  610. OTAGIRI K, Yui H, Nakamura C, Sakai T, et al
    TCT-503 Impact of Visceral Fat Accumulation on Coronary Artery Disease Severity Stratified by Computed Tomography-derived SYNTAX Score.
    J Am Coll Cardiol. 2016;68.
    >> Share

  611. AGASTHI P, Kanmanthareddy A, Egbuche O, Yarlagadda V, et al
    TCT-504 Comparison of Computed Tomography derived Fractional Flow Reserve to invasive Fractional Flow Reserve in Diagnosis of Functional Coronary Stenosis: A Meta-Analysis.
    J Am Coll Cardiol. 2016;68.
    >> Share

  612. PLEWKA M, Peruga J, Peruga J, Tondo C, et al
    TCT-501 Ultrasound examination of the forearm arteries morphology and anomalies in patients undergoing percutaneous coronary intervention via radial access.
    J Am Coll Cardiol. 2016;68.
    >> Share

  613. PARK DW, Kang SH, Park SJ, Lee PH, et al
    TCT-47 Secular Trends in Characteristics, Treatments, and Outcomes in Patients with Unprotected Left Main Coronary Artery Disease Over Two Decades.
    J Am Coll Cardiol. 2016;68.
    >> Share

  614. ENG LK, Starovoytov A, Humphries K, Mancini GB, et al
    TCT-48 Medical Therapy and Clinical Outcomes with Spontaneous Coronary Artery Dissection.
    J Am Coll Cardiol. 2016;68.
    >> Share

  615. EBRAHIMI R, Mehran R, Ben-Yehuda O, Parvataneni R, et al
    TCT-5 Risks and Benefits of Dual Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery: Insights from the ACUITY trial.
    J Am Coll Cardiol. 2016;68.
    >> Share

  616. THEODOROPOULOS K, Meelu O, Mennuni M, Sartori S, et al
    TCT-496 Differences in quantitative coronary angiographic (QCA) characteristics of coronary artery disease between Human Immunodeficiency Virus (HIV) patients presenting with acute coronary syndrome (ACS) and stable angina pectoris (SAP) undergoing pe
    J Am Coll Cardiol. 2016;68.
    >> Share

  617. KANG JH, Rha SW, Choi BG, Byun JK, et al
    TCT-497 A Novel Scoring System Predicting Major Adverse Cardiac Events in Coronary Artery Spasm Patients: A Large-scale Simulation Analysis.
    J Am Coll Cardiol. 2016;68.
    >> Share

  618. HERNANDEZ E, Diaz VJ, Juan-Salvadores P, Vitela J, et al
    TCT-491 Comparative analysis of the right radial vascular access vs. left at more than 10,000 diagnostic coronary angiography.
    J Am Coll Cardiol. 2016;68.
    >> Share

  619. KIM WH, Rha SW, Choi BG, Byun JK, et al
    TCT-489 Impact of Left Ventricular Hypertrophy on Coronary Artery Spasm as assessed by Acetylcholine Provocation Test.
    J Am Coll Cardiol. 2016;68.
    >> Share

  620. KIM YH, Rha SW, Her AY, Choi BG, et al
    TCT-490 Five-year Clinical Outcomes Are Different according to the Severity of Coronary Artery Spasm as Assessed by Intracoronary Acetylcholine Provocation Test.
    J Am Coll Cardiol. 2016;68.
    >> Share

  621. MAJUMDAR S, Krishnan H, Kumar A
    TCT-488 Congenital Coronary Anomalies of Origin and Distribution in Adult Patients referred for Coronary angiography.
    J Am Coll Cardiol. 2016;68.
    >> Share

  622. HARADA Y, Colleran R, Kufner S, Giacoppo D, et al
    TCT-483 Angiographic and two-year clinical outcomes following percutaneous coronary intervention for in-stent restenosis of polymer-free sirolimus- and probucol-eluting stent compared with durable polymer zotarolimus-eluting stent.
    J Am Coll Cardiol. 2016;68.
    >> Share

  623. DURGAPRASAD R, Vanajakshamma V, Vamsidhar A, Kasala L, et al
    TCT-485 A study of safety and efficacy of biodegradable polymer coated Everolimus-eluting coronary stent system [Everoflex] at intermediate follow-up in real world scenario.
    J Am Coll Cardiol. 2016;68.
    >> Share

  624. VOLZ S, Dworeck C, Angeras O, Haraldsson I, et al
    TCT-482 First generation drug-eluting stent is worse than contemporary bare metal stent after long-term follow-up: A report from SCAAR.
    J Am Coll Cardiol. 2016;68.
    >> Share

  625. GIL R, Bil J, Vassilev D, Kern A, et al
    TCT-480 Regular drug eluting stents versus dedicated bifurcation drug eluting BiOSS(R) stents in coronary bifurcation treatment - outcome predicting factors and long-term results of two international, multicenter, randomized POLBOS I and POLBOS II cli
    J Am Coll Cardiol. 2016;68.
    >> Share

  626. PANCHAL H, Bhattad V, Murtaza G, Vladimirov G, et al
    TCT-479 Mortality and Major Adverse Cardiovascular Events of Polymer Free Drug Coated Stents versus Polymer Based Drug Eluting Stents: A Meta-Analysis of Randomized Controlled Trials.
    J Am Coll Cardiol. 2016;68.
    >> Share

  627. DWORECK C, Angeras O, Haraldsson I, Ioanes D, et al
    TCT-477 Long-term risk of stent thrombosis and restenosis after treatment with drug-eluting stents: A report from SCAAR.
    J Am Coll Cardiol. 2016;68.
    >> Share

  628. GIUSTINO G, Melegari C, Baber U, Sartori S, et al
    TCT-475 Effect of Stent Diameter in Women Undergoing Percutaneous Coronary Intervention with Early- and New-Generation Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
    J Am Coll Cardiol. 2016;68.
    >> Share

  629. HAN Y, Yang Y, Fu G, Su XI, et al
    TCT-473 A Randomized Comparison of Biodegradable Polymer- and Permanent Polymer-coated Platinum Chromium Everolimus-Eluting Coronary Stents in China: EVOLVE China Study.
    J Am Coll Cardiol. 2016;68.
    >> Share

  630. CAMACHO FREIRE SJ, Menchero AG, Jimenez JL, Tawfik H, et al
    TCT-46 Coronary artery aneurysms: incididence, etiology, management and outcomes in a long-term follow up.
    J Am Coll Cardiol. 2016;68.
    >> Share

  631. VASSILEV D, Karamfiloff K, Dosev L, Stoykova J, et al
    TCT-45 Five Year Mortality Predictors After provisional T-stenting in Coronary Bifurcation Lesions, with Intracoronary Electrocardiogram Change Defined Strategy. From Intracoronary Electrocardiogram (ECG) and Myonecrosis After Bifurcation Stenting (CO
    J Am Coll Cardiol. 2016;68.
    >> Share

  632. VOGEL B, Baber U, Giustino G, Sartori S, et al
    TCT-471 Impact of New- versus Early-Generation Drug Eluting Stents in Women according to Age: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
    J Am Coll Cardiol. 2016;68.
    >> Share

  633. VERHEYE S, Abizaid A, Botelho R, Costa R, et al
    TCT-460 Multi-Center, Randomized Evaluation of the Elixir DESyne(R) Novolimus Eluting Coronary Stent System with Biodegradable Polymer Compared to a Zotarolimus-Eluting Coronary Stent System: Final 5-Year Results from the EXCELLA BD Study.
    J Am Coll Cardiol. 2016;68.
    >> Share

  634. KAUL U, Abhaichand DR, Patel T, Banker D, et al
    TCT-457 Paclitaxel - eluting stents vs Everolimus - eluting Coronary Stents in a Diabetic population: 2 Years Follow-up of TUXEDO-India Trial.
    J Am Coll Cardiol. 2016;68.
    >> Share

  635. VERHEYE S, Stella P, Carrie D, Khattab A, et al
    TCT-456 Direct Implantation of Rapamycin-Eluting Stents with Bioresorbable Drug Carrier Technology Utilizing the Svelte Coronary Stent-on-a-Wire: 2-Year Follow-Up of the Randomized, Controlled DIRECT II Study.
    J Am Coll Cardiol. 2016;68.
    >> Share

  636. GIUSTINO G, Baber U, Sartori S, Stone G, et al
    TCT-453 Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
    J Am Coll Cardiol. 2016;68.
    >> Share

  637. TOKLU B, Bangalore S, Kaul U, Attubato M, et al
    TCT-450 Bare Metal Stent, Durable Polymer Drug Eluting Stent, or Biodegradable Polymer Drug Eluting Stent in Patients with Diabetes Mellitus - A Mixed Treatment Comparison Analysis of 63,940 Patient-Years of Follow-up from Randomized Trials.
    J Am Coll Cardiol. 2016;68.
    >> Share

  638. SLAGBOOM T, Haude M, Lefevre T, Hayek S, et al
    TCT-448 BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II) - 4 Year Clinical Results.
    J Am Coll Cardiol. 2016;68.
    >> Share

  639. TORII S, Kolodgie F, Cheng D, Acampado E, et al
    TCT-446 Fluoropassivation of Coronary Stents as a Potential Mechanism of Improved Thromboresistance.
    J Am Coll Cardiol. 2016;68.
    >> Share

  640. LEE SY, Torguson R, Garcia-Garcia HM, Tang G, et al
    TCT-445 Does the Risk of Bleeding Impacts Selection of Stent Type during Percutaneous Coronary Intervention?
    J Am Coll Cardiol. 2016;68.
    >> Share

    October 2016
  641. LLOYD-JONES DM, Huffman MD, Karmali KN, Sanghavi DM, et al
    Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool.
    J Am Coll Cardiol. 2016 Oct 28. pii: S0735-1097(16)36692.
    >> Share

  642. OUWENEEL DM, Eriksen E, Sjauw KD, van Dongen IM, et al
    Impella CP Versus Intra-Aortic Balloon Pump in Acute Myocardial Infarction Complicated by Cardiogenic Shock: The IMPRESS trial.
    J Am Coll Cardiol. 2016 Oct 27. pii: S0735-1097(16)36767.
    >> Share

  643. KINI AS, Vengrenyuk Y, Shameer K, Maehara A, et al
    Intracoronary Imaging, Cholesterol Efflux, and Transcriptomes after Intensive Statin Treatment: The YELLOW II study.
    J Am Coll Cardiol. 2016 Oct 27. pii: S0735-1097(16)36776.
    >> Share

  644. JONES WS, Roe MT, Antman EM, Pletcher MJ, et al
    The Changing Landscape of Randomized Clinical Trials in Cardiovascular Disease.
    J Am Coll Cardiol. 2016;68:1898-1907.
    >> Share

  645. WELSH RC, Peterson ED
    Selecting the Duration of Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Complex Decision or Not?
    J Am Coll Cardiol. 2016;68:1865-1867.
    >> Share

  646. MECHANICK JI, Zhao S, Garvey WT
    The Adipokine-Cardiovascular-Lifestyle Network: Translation to Clinical Practice.
    J Am Coll Cardiol. 2016;68:1785-1803.
    >> Share

  647. WEVER-PINZON J, Selzman CH, Stoddard G, Wever-Pinzon O, et al
    Impact of Ischemic Heart Failure Etiology on Cardiac Recovery During Mechanical Unloading.
    J Am Coll Cardiol. 2016;68:1741-1752.
    >> Share

  648. NARANG A, Sinha SS, Rajagopalan B, Ijioma NN, et al
    The Supply and Demand of the Cardiovascular Workforce: Striking the Right Balance.
    J Am Coll Cardiol. 2016;68:1680-1689.
    >> Share

  649. RAPHAEL CE, Cooper R, Parker KH, Collinson J, et al
    Mechanisms of Myocardial Ischemia in Hypertrophic Cardiomyopathy: Insights From Wave Intensity Analysis and Magnetic Resonance.
    J Am Coll Cardiol. 2016;68:1651-1660.
    >> Share

  650. BRILAKIS ES, Abdullah SM, Banerjee S
    Who Should Undergo Chronic Total Occlusion Percutaneous Coronary Intervention?: The EXPLORation Continues.
    J Am Coll Cardiol. 2016;68:1633-1636.
    >> Share

  651. GUPTA SK, Foinquinos A, Thum S, Remke J, et al
    Preclinical Development of a MicroRNA-Based Therapy for Elderly Patients With Myocardial Infarction.
    J Am Coll Cardiol. 2016;68:1557-71.
    >> Share

  652. NEELAND IJ, de Lemos JA
    Time to Retire the BMI?: Evaluating Abdominal Adipose Tissue Imaging as Novel Cardiovascular Risk Biomarker.
    J Am Coll Cardiol. 2016;68:1522-4.
    >> Share

  653. LEE JJ, Pedley A, Hoffmann U, Massaro JM, et al
    Association of Changes in Abdominal Fat Quantity and Quality With Incident Cardiovascular Disease Risk Factors.
    J Am Coll Cardiol. 2016;68:1509-21.
    >> Share

    September 2016
  654. GOSMANOVA EO, Mikkelsen MK, Molnar MZ, Lu JL, et al
    Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease.
    J Am Coll Cardiol. 2016;68:1375-86.
    >> Share

  655. JOHANSSON I, Dahlstrom U, Edner M, Nasman P, et al
    Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure.
    J Am Coll Cardiol. 2016;68:1404-16.
    >> Share

  656. PILOTE L
    Reply: Sex Versus Gender in Recurrent Events Following Acute Coronary Syndrome: A "Femininity Paradox?".
    J Am Coll Cardiol. 2016;68:1372.
    >> Share

  657. PAULUS JK, Kent DM
    Sex Versus Gender in Recurrent Events Following Acute Coronary Syndrome: A "Femininity Paradox?".
    J Am Coll Cardiol. 2016;68:1371-2.
    >> Share

  658. KUVIN JT, Williams ES
    Defining, Achieving, and Maintaining Competence in Cardiovascular Training and Practice.
    J Am Coll Cardiol. 2016;68:1342-7.
    >> Share

  659. FAN Y, Li Y, Chen Y, Zhao YJ, et al
    Comprehensive Metabolomic Characterization of Coronary Artery Diseases.
    J Am Coll Cardiol. 2016;68:1281-93.
    >> Share

  660. ACKERMAN MJ, Giudicessi JR
    Post-Mortem Cardiovascular Implantable Electronic Device Interrogation: Clinical Indications and Potential Benefits.
    J Am Coll Cardiol. 2016;68:1265-7.
    >> Share

  661. SINHA SK, Crain B, Flickinger K, Calkins H, et al
    Clinical Inferences of Cardiovascular Implantable Electronic Device Analysis at Autopsy.
    J Am Coll Cardiol. 2016;68:1255-64.
    >> Share

  662. VAUSORT M, Salgado-Somoza A, Zhang L, Leszek P, et al
    Myocardial Infarction-Associated Circular RNA Predicting Left Ventricular Dysfunction.
    J Am Coll Cardiol. 2016;68:1247-8.
    >> Share

  663. ALEXOPOULOS D, Xanthopoulou I, Moulias A, Lekakis J, et al
    Long-Term P2Y12-Receptor Antagonists in Post-Myocardial Infarction Patients: Facing a New Trilemma?
    J Am Coll Cardiol. 2016;68:1223-32.
    >> Share

  664. LEE PH, Ahn JM, Chang M, Baek S, et al
    Left Main Coronary Artery Disease: Secular Trends in Patient Characteristics, Treatments, and Outcomes.
    J Am Coll Cardiol. 2016;68:1233-46.
    >> Share

  665. FEARON WF, De Bruyne B, Pijls NH
    Fractional Flow Reserve in Acute Coronary Syndromes.
    J Am Coll Cardiol. 2016;68:1192-4.
    >> Share

  666. HAKEEM A, Edupuganti MM, Almomani A, Pothineni NV, et al
    Long-Term Prognosis of Deferred Acute Coronary Syndrome Lesions Based on Nonischemic Fractional Flow Reserve.
    J Am Coll Cardiol. 2016;68:1181-91.
    >> Share

  667. BATES ER, Tamis-Holland JE, Bittl JA, O'Gara PT, et al
    PCI Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease.
    J Am Coll Cardiol. 2016;68:1066-81.
    >> Share

  668. MANCINI GB, Farkouh ME, Brooks MM, Chaitman BR, et al
    Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease.
    J Am Coll Cardiol. 2016;68:985-95.
    >> Share

  669. WINDECKER S, Piccolo R
    Myocardial Revascularization for Left Main Coronary Artery Disease: A Step Toward Individualized Treatment Selection.
    J Am Coll Cardiol. 2016;68:1010-3.
    >> Share

  670. CAVALCANTE R, Sotomi Y, Lee CW, Ahn JM, et al
    Outcomes After Percutaneous Coronary Intervention or Bypass Surgery in Patients With Unprotected Left Main Disease.
    J Am Coll Cardiol. 2016;68:999-1009.
    >> Share

    August 2016
  671. EVERETT BM, Brooks MM, Vlachos HE, Chaitman BR, et al
    Sex Differences in Cardiac Troponin and the Risk of Death or Major Cardiovascular Events.
    J Am Coll Cardiol. 2016;68:978-80.
    >> Share

  672. LEVIN A, Lan JH
    Cystatin C and Cardiovascular Disease: Causality, Association, and Clinical Implications of Knowing the Difference.
    J Am Coll Cardiol. 2016;68:946-8.
    >> Share

  673. VAN DER LAAN SW, Fall T, Soumare A, Teumer A, et al
    Cystatin C and Cardiovascular Disease: A Mendelian Randomization Study.
    J Am Coll Cardiol. 2016;68:934-45.
    >> Share

  674. SUTTON NR, Seth M, Ruwende C, Gurm HS, et al
    Outcomes of Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68:895-904.
    >> Share

  675. SELVARAJ S, Bhatt DL, Stone GW, Gibson CM, et al
    "Off-Hours" Versus "On-Hours" Presentation in ST-Segment Elevation Myocardial Infarction: Findings from CHAMPION PHOENIX.
    J Am Coll Cardiol. 2016 Aug 25. pii: S0735-1097(16)35036.
    >> Share

  676. ATKINS JL, Pilling LC, Ble A, Dutta A, et al
    Longer-Lived Parents and Cardiovascular Outcomes: 8-Year Follow-Up In 186,000 U.K. Biobank Participants.
    J Am Coll Cardiol. 2016;68:874-5.
    >> Share

  677. LABARTHE DR, Kubzansky LD, Boehm JK, Lloyd-Jones DM, et al
    Positive Cardiovascular Health: A Timely Convergence.
    J Am Coll Cardiol. 2016;68:860-7.
    >> Share

  678. VORSANGER MH, Subramanyam P, Weintraub HS, Lamm SH, et al
    Cardiovascular Effects of the New Weight Loss Agents.
    J Am Coll Cardiol. 2016;68:849-59.
    >> Share

  679. BLOOMFIELD GS, Leung Yinko SS
    A Series of Unhealthy Developments: The Multiple Facets of Cardiovascular Risk Factors in China.
    J Am Coll Cardiol. 2016;68:834-5.
    >> Share

  680. LI Y, Wang DD, Ley SH, Howard AG, et al
    Potential Impact of Time Trend of Life-Style Factors on Cardiovascular Disease Burden in China.
    J Am Coll Cardiol. 2016;68:818-33.
    >> Share

  681. BANSILAL S, Castellano JM, Garrido E, Wei HG, et al
    Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes.
    J Am Coll Cardiol. 2016;68:789-801.
    >> Share

  682. RAO SV, Zeymer U, Douglas PS, Al-Khalidi H, et al
    Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction.
    J Am Coll Cardiol. 2016;68:715-23.
    >> Share

  683. CALIFF RM
    The Future of Cardiovascular Medicine From the Regulatory Perspective.
    J Am Coll Cardiol. 2016;68:766-9.
    >> Share

  684. HENRIQUES JP, Kikkert WJ
    Intracoronary Abciximab in Diabetic STEMI Patients: Questionable Benefit, Proven Harm.
    J Am Coll Cardiol. 2016;68:739-41.
    >> Share

  685. PICCOLO R, Eitel I, Galasso G, Dominguez-Rodriguez A, et al
    1-Year Outcomes With Intracoronary Abciximab in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68:727-38.
    >> Share

  686. SOLOMON MD, Leong TK, Rana JS, Xu Y, et al
    Community-Based Trends in Acute Myocardial Infarction From 2008 to 2014.
    J Am Coll Cardiol. 2016;68:666-8.
    >> Share

  687. WILSON PW, D'Agostino RB Sr
    No One Size Fits All: Scoring Risk of In-Hospital Death After Myocardial Infarction.
    J Am Coll Cardiol. 2016;68:636-8.
    >> Share

  688. MCNAMARA RL, Kennedy KF, Cohen DJ, Diercks DB, et al
    Predicting In-Hospital Mortality in Patients With Acute Myocardial Infarction.
    J Am Coll Cardiol. 2016;68:626-35.
    >> Share

  689. GAUDINO M, Tondi P, Benedetto U, Milazzo V, et al
    Radial Artery as a Coronary Artery Bypass Conduit: 20-Year Results.
    J Am Coll Cardiol. 2016;68:603-10.
    >> Share

  690. RIBEIRO HB, Orwat S, Hayek SS, Larose E, et al
    Cardiovascular Magnetic Resonance to Evaluate Aortic Regurgitation After Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2016;68:577-85.
    >> Share

  691. YOUNG JB, Stehlik J
    Ischemic Heart Disease in New-Onset Heart Failure, or Finding Waldo: Where's Waldo?
    J Am Coll Cardiol. 2016;68:459-60.
    >> Share

  692. DOUGLAS PS, De Bruyne B, Pontone G, Patel MR, et al
    1-Year Outcomes of FFRCT-Guided Care in Patients With Suspected Coronary Disease: The PLATFORM Study.
    J Am Coll Cardiol. 2016;68:435-45.
    >> Share

  693. ELGENDY IY, Mahmoud AN, Elgendy AY, Bavry AA, et al
    Does the Baseline Coronary Lesion Length Impact Outcomes With IVUS-Guided Percutaneous Coronary Intervention?
    J Am Coll Cardiol. 2016;68:569-70.
    >> Share

  694. DOSHI D, Ben-Yehuda O, Bonafede M, Josephy N, et al
    Underutilization of Coronary Artery Disease Testing Among Patients Hospitalized With New-Onset Heart Failure.
    J Am Coll Cardiol. 2016;68:450-8.
    >> Share

    July 2016
  695. HAWRANEK M, Wrobel M, Nozynski J, Pres D, et al
    Hemorrhagic Myocardial Infarction: Mortality Compared With STEMI Patients Treated With Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68:426-7.
    >> Share

  696. DAUERMAN HL
    The Expanding Universe of Perioperative Myocardial Infarction.
    J Am Coll Cardiol. 2016;68:339-42.
    >> Share

  697. PARASHAR A, Agarwal S, Krishnaswamy A, Sud K, et al
    Percutaneous Intervention for Myocardial Infarction After Noncardiac Surgery: Patient Characteristics and Outcomes.
    J Am Coll Cardiol. 2016;68:329-38.
    >> Share

  698. KHAN A, Gilani S, Dharmashankar K, Jaffery Z, et al
    Percutaneous Coronary Intervention After Transcatheter Aortic Valve Replacement: Approach and Challenges.
    J Am Coll Cardiol. 2016;68:432-3.
    >> Share

  699. DIEGELER A
    Hybrid Coronary Revascularization: The Best of 2 Worlds?
    J Am Coll Cardiol. 2016;68:366-7.
    >> Share

  700. PUSKAS JD, Halkos ME, DeRose JJ, Bagiella E, et al
    Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease: A Multicenter Observational Study.
    J Am Coll Cardiol. 2016;68:356-65.
    >> Share

  701. OKADA K, Fearon WF, Luikart H, Kitahara H, et al
    Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy.
    J Am Coll Cardiol. 2016;68:382-92.
    >> Share

  702. BONACA MP, O'Malley RG, Jarolim P, Scirica BM, et al
    Serial Cardiac Troponin Measured Using a High-Sensitivity Assay in Stable Patients With Ischemic Heart Disease.
    J Am Coll Cardiol. 2016;68:322-3.
    >> Share

  703. HASIN T, Gerber Y, Weston SA, Jiang R, et al
    Heart Failure After Myocardial Infarction Is Associated With Increased Risk of Cancer.
    J Am Coll Cardiol. 2016;68:265-71.
    >> Share

  704. SAW J, Mancini GB, Humphries KH
    Contemporary Review on Spontaneous Coronary Artery Dissection.
    J Am Coll Cardiol. 2016;68:297-312.
    >> Share

  705. BESSELING J, Hovingh GK, Huijgen R, Kastelein JJ, et al
    Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause Mortality.
    J Am Coll Cardiol. 2016;68:252-60.
    >> Share

  706. MANGIACAPRA F, Di Gioia G, Pellicano M, Di Serafino L, et al
    Effects of Prasugrel Versus Clopidogrel on Coronary Microvascular Function in Patients Undergoing Elective PCI.
    J Am Coll Cardiol. 2016;68:235-7.
    >> Share

  707. SIASOS G, Stefanadis C, Tousoulis D
    Factors Affecting Platelet Reactivity and Cardiovascular Outcome in CAD Patients Treated With P2Y12 Receptor Inhibitors.
    J Am Coll Cardiol. 2016;68:134.
    >> Share

  708. SELVARAJ S, Steg PG, Elbez Y, Sorbets E, et al
    Reply: Pulse Pressure and Cardiovascular Death.
    J Am Coll Cardiol. 2016;68:132-3.
    >> Share

  709. AZNAOURIDIS K, Vlachopoulos C, Tousoulis D
    Pulse Pressure and Cardiovascular Death.
    J Am Coll Cardiol. 2016;68:131-2.
    >> Share

  710. CHANG M, Ahn JM, Lee CW, Cavalcante R, et al
    Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease.
    J Am Coll Cardiol. 2016;68:29-36.
    >> Share

    June 2016
  711. MURPHY SA, Cannon CP, Blazing MA, Giugliano RP, et al
    Reply: Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful?
    J Am Coll Cardiol. 2016;67:3025-6.
    >> Share

  712. MASCITELLI L, Goldstein MR
    Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful?
    J Am Coll Cardiol. 2016;67:3025.
    >> Share

  713. SEALS AA
    ACC International Outreach and the Global Cardiovascular Community.
    J Am Coll Cardiol. 2016;67:3011-3.
    >> Share

  714. WEINRAUCH LA, Segal AR, D'Elia JA
    Cardiovascular Risk Reduction and the Community Pharmacist.
    J Am Coll Cardiol. 2016;67:2855-7.
    >> Share

  715. KO MJ, Jo AJ, Park CM, Kim HJ, et al
    Level of Blood Pressure Control and Cardiovascular Events: SPRINT Criteria Versus the 2014 Hypertension Recommendations.
    J Am Coll Cardiol. 2016;67:2821-31.
    >> Share

  716. HIATT WR, Rogers RK
    The Development of Therapeutics for Peripheral Artery Disease: A Unique Cardiovascular Risk Population.
    J Am Coll Cardiol. 2016;67:2729-31.
    >> Share

  717. SCHMID-SCHONBEIN GW
    Can Fishy Odor Be a Risk Factor for Coronary Artery Disease?
    J Am Coll Cardiol. 2016;67:2629-30.
    >> Share

  718. GIDDING SS
    Familial Hypercholesterolemia: Now Part of Cardiovascular Disease Genetic Epidemiology Research.
    J Am Coll Cardiol. 2016;67:2590-2.
    >> Share

    May 2016
  719. ANTIOCHOS P, Marques-Vidal P, Vollenweider P
    Genetic Scores and Prediction of Atherosclerotic Cardiovascular Disease: Moving From Short-Term to Lifetime Risk Assessment.
    J Am Coll Cardiol. 2016;67:2558-9.
    >> Share

  720. MAHMUD E, Behnamfar O, Lin F, Reeves R, et al
    Elevated Serum Fibrinogen Is Associated With 12-Month Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;67:2556-7.
    >> Share

  721. STONE GW
    DAPT Duration After Coronary Stenting: Assessing Risk-Benefit Tradeoffs in Individual Patients.
    J Am Coll Cardiol. 2016;67:2503-5.
    >> Share

  722. MODY P, Joshi PH, Khera A, Ayers CR, et al
    Beyond Coronary Calcification, Family History, and C-Reactive Protein: Cholesterol Efflux Capacity and Cardiovascular Risk Prediction.
    J Am Coll Cardiol. 2016;67:2480-7.
    >> Share

  723. MATHIAS W JR, Tsutsui JM, Tavares BG, Xie F, et al
    Diagnostic Ultrasound Impulses Improve Microvascular Flow in Patients With STEMI Receiving Intravenous Microbubbles.
    J Am Coll Cardiol. 2016;67:2506-2515.
    >> Share

  724. LAMAS GA, Navas-Acien A, Mark DB, Lee KL, et al
    Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy.
    J Am Coll Cardiol. 2016;67:2411-8.
    >> Share

  725. MENTZ RJ, Newby LK, Neely B, Lucas JE, et al
    Assessment of Administrative Data to Identify Acute Myocardial Infarction in Electronic Health Records.
    J Am Coll Cardiol. 2016;67:2441-2.
    >> Share

  726. BUCHOLZ EM, Butala NM, Normand SL, Wang Y, et al
    Association of Guideline-Based Admission Treatments and Life Expectancy After Myocardial Infarction in Elderly Medicare Beneficiaries.
    J Am Coll Cardiol. 2016;67:2378-91.
    >> Share

  727. NAPPI F, Lusini M, Spadaccio C, Nenna A, et al
    Papillary Muscle Approximation Versus Restrictive Annuloplasty Alone for Severe Ischemic Mitral Regurgitation.
    J Am Coll Cardiol. 2016;67:2334-46.
    >> Share

  728. EGBE AC, Luis SA, Padang R, Warnes CA, et al
    Outcomes in Moderate Mixed Aortic Valve Disease: Is it Time for a Paradigm Shift?
    J Am Coll Cardiol. 2016;67:2321-9.
    >> Share

  729. SINNECKER D, Dommasch M, Steger A, Berkefeld A, et al
    Expiration-Triggered Sinus Arrhythmia Predicts Outcome in Survivors of Acute Myocardial Infarction.
    J Am Coll Cardiol. 2016;67:2213-20.
    >> Share

  730. MINER SE, Nield LE
    Obesity Cardiovascular Disease and the Failure of Public Health Education.
    J Am Coll Cardiol. 2016;67:2315-6.
    >> Share

  731. FABRIS F, Rice TK, Jeffe DB, Czajkowski SM, et al
    Junior Faculty Career Development Through an NHLBI Program to Increase Diversity in Cardiovascular Health-Related Research.
    J Am Coll Cardiol. 2016;67:2312-3.
    >> Share

  732. BROWNELL NK, Khera A, de Lemos JA, Ayers CR, et al
    Association Between Peptidoglycan Recognition Protein-1 and Incident Atherosclerotic Cardiovascular Disease Events: The Dallas Heart Study.
    J Am Coll Cardiol. 2016;67:2310-2.
    >> Share

  733. WENGER NK, Ouyang P, Miller VM, Bairey Merz CN, et al
    Strategies and Methods for Clinical Scientists to Study Sex-Specific Cardiovascular Health and Disease in Women.
    J Am Coll Cardiol. 2016;67:2186-8.
    >> Share

  734. VRANCKX P, White HD, Huang Z, Mahaffey KW, et al
    Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial.
    J Am Coll Cardiol. 2016;67:2135-44.
    >> Share

  735. RANA JS, Tabada GH, Solomon MD, Lo JC, et al
    Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population.
    J Am Coll Cardiol. 2016;67:2118-30.
    >> Share

    April 2016
  736. PITT B
    MRAs in Patients With AMI Without Early Evidence of Heart Failure: Time for Reappraisal?
    J Am Coll Cardiol. 2016;67:1928-30.
    >> Share

  737. ZEB I, Li D, Budoff MJ, Katz R, et al
    Nonalcoholic Fatty Liver Disease and Incident Cardiac Events: The Multi-Ethnic Study of Atherosclerosis.
    J Am Coll Cardiol. 2016;67:1965-6.
    >> Share

  738. TORNVALL P, Collste O, Ehrenborg E, Jarnbert-Petterson H, et al
    A Case-Control Study of Risk Markers and Mortality in Takotsubo Stress Cardiomyopathy.
    J Am Coll Cardiol. 2016;67:1931-6.
    >> Share

  739. FERNANDEZ-JIMENEZ R, Fuster V, Ibanez B
    Reply: "Waves of Edema" Seem Implausible.
    J Am Coll Cardiol. 2016;67:1869-70.
    >> Share

  740. BERRY C, Carrick D, Haig C, Oldroyd KG, et al
    "Waves of Edema" Seem Implausible.
    J Am Coll Cardiol. 2016;67:1868-9.
    >> Share

  741. ISHII M, Kaikita K, Ogawa H
    Reply: Could Plaque Composition-Related Endothelial Dysfunction Predict Poor Prognosis in Coronary Vasospastic Angina?
    J Am Coll Cardiol. 2016;67:1867-8.
    >> Share

  742. ORTEGA-PAZ L, Garcia-Garcia HM, Brugaletta S
    Could Plaque Composition-Related Endothelial Dysfunction Predict Poor Prognosis in Coronary Vasospastic Angina?
    J Am Coll Cardiol. 2016;67:1867.
    >> Share

  743. NISSEN SE
    IVUS Virtual Histology: Unvalidated Gimmick or Useful Technique?
    J Am Coll Cardiol. 2016;67:1784-5.
    >> Share

  744. PARK SJ, Kang SJ, Ahn JM, Chang M, et al
    Effect of Statin Treatment on Modifying Plaque Composition: A Double-Blind, Randomized Study.
    J Am Coll Cardiol. 2016;67:1772-83.
    >> Share

  745. MIN JK, Jones EC, Pena JM
    The Future From the Past: A Chance for Change.
    J Am Coll Cardiol. 2016;67:1769-71.
    >> Share

  746. VERMOND RA, Geelhoed B, Rienstra M
    Reply: Antihypertensive Drug Usage in Prediction of Incident Atrial Fibrillation: A Factor Not To Be Disregarded.
    J Am Coll Cardiol. 2016;67:1754-5.
    >> Share

  747. ONAT A, Simsek B, Akbas T
    Antihypertensive Drug Usage in Prediction of Incident Atrial Fibrillation: A Factor Not to Be Disregarded.
    J Am Coll Cardiol. 2016;67:1753-4.
    >> Share

  748. NEWBURGER JW, Takahashi M, Burns JC
    Kawasaki Disease.
    J Am Coll Cardiol. 2016;67:1738-49.
    >> Share

  749. NAPPI AG, Boden WE
    Does Physiology Trump Anatomy as the "Best Course" to Guide PCI Decision Making and Outcomes?
    J Am Coll Cardiol. 2016;67:1712-4.
    >> Share

  750. GIBBONS RJ, Araoz P
    Does Infarct Size Matter?
    J Am Coll Cardiol. 2016;67:1684-6.
    >> Share

  751. STONE GW, Selker HP, Thiele H, Patel MR, et al
    Relationship Between Infarct Size and Outcomes Following Primary PCI: Patient-Level Analysis From 10 Randomized Trials.
    J Am Coll Cardiol. 2016;67:1674-83.
    >> Share

  752. VADUGANATHAN M, Bhatt DL, Cryer BL, Liu Y, et al
    Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.
    J Am Coll Cardiol. 2016;67:1661-71.
    >> Share

  753. FUSTER V
    What Makes General Cardiovascular Education Courses Successful?
    J Am Coll Cardiol. 2016;67:1651-2.
    >> Share

  754. KARIO K, Saito I, Kushiro T, Teramukai S, et al
    Morning Home Blood Pressure Is a Strong Predictor of Coronary Artery Disease: The HONEST Study.
    J Am Coll Cardiol. 2016;67:1519-27.
    >> Share

  755. SMITH SC JR
    Adherence to Medical Therapy and the Global Burden of Cardiovascular Disease.
    J Am Coll Cardiol. 2016;67:1516-8.
    >> Share

    March 2016
  756. TRANBAUGH RF, Schwann TA, Habib RH
    Reply: CABG Versus PCI: Are All Revascularization Strategies Created Equal?
    J Am Coll Cardiol. 2016;67:1504-5.
    >> Share

  757. PHILIP F, Southard JA
    CABG Versus PCI: Are All Revascularization Strategies Created Equal?
    J Am Coll Cardiol. 2016;67:1503-4.
    >> Share

  758. HENDERSON RA, Jarvis C, Clayton T, Pocock SJ, et al
    Reply: Do the 10-Year Mortality Outcomes of RITA-3 Inform Contemporary Clinical Practice?
    J Am Coll Cardiol. 2016;67:1502-3.
    >> Share

  759. MCDANIEL M, Wenger N
    Do the 10-Year Mortality Outcomes of RITA-3 Inform Contemporary Clinical Practice?
    J Am Coll Cardiol. 2016;67:1502.
    >> Share

  760. CHANG TI, Montez-Rath ME, Tsai TT, Hlatky MA, et al
    Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis.
    J Am Coll Cardiol. 2016;67:1459-69.
    >> Share

  761. LACLAUSTRA M, Casasnovas JA, Fernandez-Ortiz A, Fuster V, et al
    Femoral and Carotid Subclinical Atherosclerosis Association With Risk Factors and Coronary Calcium: The AWHS Study.
    J Am Coll Cardiol. 2016;67:1263-74.
    >> Share

  762. BOON RA, Jae N, Holdt L, Dimmeler S, et al
    Long Noncoding RNAs: From Clinical Genetics to Therapeutic Targets?
    J Am Coll Cardiol. 2016;67:1214-26.
    >> Share

  763. BRAR SS
    The Yin and Yang of Long-Term Dual Antiplatelet Therapy.
    J Am Coll Cardiol. 2016;67:1155-7.
    >> Share

  764. STOREY RF, Angiolillo DJ, Bonaca MP, Thomas MR, et al
    Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial.
    J Am Coll Cardiol. 2016;67:1145-54.
    >> Share

  765. WALLER C, Bauersachs J, Hoppmann U, Hoch J, et al
    Blunted Cortisol Stress Response and Depression-Induced Hypocortisolism Is Related to Inflammation in Patients With CAD.
    J Am Coll Cardiol. 2016;67:1124-6.
    >> Share

  766. COSTA KD
    Decellularized Scaffold Hydrogel Materials for MI Treatment: Could "The Matrix" Really Be the Future?
    J Am Coll Cardiol. 2016;67:1087-90.
    >> Share

  767. WASSENAAR JW, Gaetani R, Garcia JJ, Braden RL, et al
    Evidence for Mechanisms Underlying the Functional Benefits of a Myocardial Matrix Hydrogel for Post-MI Treatment.
    J Am Coll Cardiol. 2016;67:1074-86.
    >> Share

  768. RADFORD MJ
    Does Public Reporting Improve Care?
    J Am Coll Cardiol. 2016;67:973-5.
    >> Share

  769. DEVORE AD, Hammill BG, Hardy NC, Eapen ZJ, et al
    Has Public Reporting of Hospital Readmission Rates Affected Patient Outcomes?: Analysis of Medicare Claims Data.
    J Am Coll Cardiol. 2016;67:963-72.
    >> Share

  770. BARBANTI M
    TAVR and Left Main Stenting: Can 2 Giants Live in Harmony in a Small Room?
    J Am Coll Cardiol. 2016;67:961-2.
    >> Share

  771. CHAKRAVARTY T, Sharma R, Abramowitz Y, Kapadia S, et al
    Outcomes in Patients With Transcatheter Aortic Valve Replacement and Left Main Stenting: The TAVR-LM Registry.
    J Am Coll Cardiol. 2016;67:951-60.
    >> Share

  772. SIBBING D, Gross L, Massberg S
    CYP2C19 in ACS Patients: Could Genotyping Have a Role in Medically Managed Patients or Beyond?
    J Am Coll Cardiol. 2016;67:948-50.
    >> Share

  773. DOLL JA, Neely ML, Roe MT, Armstrong PW, et al
    Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel.
    J Am Coll Cardiol. 2016;67:936-47.
    >> Share

  774. CASSESE S, Kastrati A
    Bioresorbable Vascular Scaffold Technology Benefits From Healthy Skepticism.
    J Am Coll Cardiol. 2016;67:932-5.
    >> Share

  775. PURICEL S, Cuculi F, Weissner M, Schmermund A, et al
    Bioresorbable Coronary Scaffold Thrombosis: Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and Predictors.
    J Am Coll Cardiol. 2016;67:921-31.
    >> Share

    February 2016
  776. FORDYCE CB, Newby DE, Douglas PS
    Diagnostic Strategies for the Evaluation of Chest Pain: Clinical Implications From SCOT-HEART and PROMISE.
    J Am Coll Cardiol. 2016;67:843-52.
    >> Share

  777. FUSTER V
    Editor-in-Chief's Top Picks From 2015: Part Two.
    J Am Coll Cardiol. 2016;67:817-42.
    >> Share

  778. HOLMES DR JR, Mack MJ
    Here Today, Gone Tomorrow.
    J Am Coll Cardiol. 2016;67:777-9.
    >> Share

  779. BARTHELEMY O, Montalescot G
    Moving Toward Eradication of Stent Thrombosis.
    J Am Coll Cardiol. 2016;67:763-5.
    >> Share

  780. JENSEN LO, Thayssen P, Christiansen EH, Maeng M, et al
    Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents: 5-Year Results From SORT OUT IV.
    J Am Coll Cardiol. 2016;67:751-62.
    >> Share

  781. KASTRATI A, Colleran R, Ndrepepa G
    Cardiogenic Shock: How Long Does the Storm Last?
    J Am Coll Cardiol. 2016;67:748-50.
    >> Share

  782. SILVAIN J, Kerneis M, Montalescot G
    Potent P2Y12 Inhibitors in Low-Risk Patients: Is There a Medical Need?
    J Am Coll Cardiol. 2016;67:614-7.
    >> Share

  783. ANGIOLILLO DJ, Franchi F, Waksman R, Sweeny JM, et al
    Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI.
    J Am Coll Cardiol. 2016;67:603-13.
    >> Share

  784. HENDERSON RA, Jarvis C, Clayton T, Pocock SJ, et al
    Reply: Survival Differences in Clinical Trials With Long-Term Follow-up.
    J Am Coll Cardiol. 2016;67:601.
    >> Share

  785. KOSTIS WJ, Moreyra AE, Cabrera J, Kostis JB, et al
    Survival Differences in Clinical Trials With Long-Term Follow-Up.
    J Am Coll Cardiol. 2016;67:600.
    >> Share

  786. NISHIMIYA K, Matsumoto Y, Takahashi J, Uzuka H, et al
    Enhanced Adventitial Vasa Vasorum Formation in Patients With Vasospastic Angina: Assessment With OFDI.
    J Am Coll Cardiol. 2016;67:598-600.
    >> Share

  787. JATENE T, Harrington RA, Stone GW, Steg PG, et al
    Investigator-Reported Bleeding Versus Post Hoc Adjudication of Bleeding: Lessons From the CHAMPION PHOENIX Trial.
    J Am Coll Cardiol. 2016;67:596-8.
    >> Share

  788. GRADMAN AH
    SPRINT: To Whom Do the Results Apply?
    J Am Coll Cardiol. 2016;67:473-5.
    >> Share

  789. BRESS AP, Tanner RM, Hess R, Colantonio LD, et al
    Generalizability of SPRINT Results to the U.S. Adult Population.
    J Am Coll Cardiol. 2016;67:463-72.
    >> Share

  790. MARIAN AJ
    Genetic Causality in Complex Traits: The Case of Uric Acid.
    J Am Coll Cardiol. 2016;67:417-9.
    >> Share

  791. KEENAN T, Zhao W, Rasheed A, Ho WK, et al
    Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study.
    J Am Coll Cardiol. 2016;67:407-16.
    >> Share

  792. CHEN-SCARABELLI C, Scarabelli TM
    Cyclosporine A Prior to Primary PCI in STEMI Patients: The Coup de Grace to Post-Conditioning?
    J Am Coll Cardiol. 2016;67:375-8.
    >> Share

  793. WRIGHT RS, Murphy J
    PROVE-IT to IMPROVE-IT: Why LDL-C Goals Still Matter in Post-ACS Patients.
    J Am Coll Cardiol. 2016;67:362-4.
    >> Share

    January 2016
  794. ALFONSO F, Perez Vizcayno MJ, Cardenas A, Garcia Del Blanco B, et al
    Reply: Drug-Coated Balloon Treatment as Default Strategy for DES-ISR.
    J Am Coll Cardiol. 2016;67:348-9.
    >> Share

  795. SCHELLER B, Ong PJ, Kleber F
    Drug-Coated Balloon Treatment as Default Strategy for DES-ISR.
    J Am Coll Cardiol. 2016;67:346-7.
    >> Share

  796. HENRIQUES JP, Claessen BE
    A SMILE and a Frown: One-Stage or Multistage PCI in NSTEMI Patients With Multivessel Disease.
    J Am Coll Cardiol. 2016;67:273-4.
    >> Share

  797. SARDELLA G, Lucisano L, Garbo R, Pennacchi M, et al
    Single-Staged Compared With Multi-Staged PCI in Multivessel NSTEMI Patients: The SMILE Trial.
    J Am Coll Cardiol. 2016;67:264-72.
    >> Share

  798. ABDEL-WAHAB M, Richardt G
    Reply: Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves: CHOICE Trial Results.
    J Am Coll Cardiol. 2016;67:236-7.
    >> Share

  799. MONTONE RA, Testa L, Bedogni F
    Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves: CHOICE Trial Results.
    J Am Coll Cardiol. 2016;67:235-6.
    >> Share

  800. GIRAL P, Hansel B, Chapman J
    Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression After PCI: PRECISE-IVUS.
    J Am Coll Cardiol. 2016;67:234.
    >> Share

  801. TSUJITA K, Sugiyama S, Shimomura H, Yamanaga K, et al
    Reply: Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression After PCI: PRECISE-IVUS.
    J Am Coll Cardiol. 2016;67:234-5.
    >> Share

  802. MILLWOOD IY, Bennett DA, Walters RG, Clarke R, et al
    Lipoprotein-Associated Phospholipase A2 Loss-of-Function Variant and Risk of Vascular Diseases in 90,000 Chinese Adults.
    J Am Coll Cardiol. 2016;67:230-1.
    >> Share

  803. SCHIEBINGER L, Stefanick ML
    Gender Matters in Biological Research and Medical Practice.
    J Am Coll Cardiol. 2016;67:136-8.
    >> Share

  804. TSUJITA K, Sugiyama S, Shimomura H, Yamanaga K, et al
    Reply: Getting What the Guidelines Stated Matters.
    J Am Coll Cardiol. 2016;67:120-1.
    >> Share

  805. STONE NJ, Lloyd-Jones D, Smith S
    Getting What the Guidelines Stated Matters.
    J Am Coll Cardiol. 2016;67:119-20.
    >> Share

  806. BUDAJ A
    Bleeding and Quality of Life.
    J Am Coll Cardiol. 2016;67:66-8.
    >> Share

  807. AMIN AP, Wang TY, McCoy L, Bach RG, et al
    Impact of Bleeding on Quality of Life in Patients on DAPT: Insights From TRANSLATE-ACS.
    J Am Coll Cardiol. 2016;67:59-65.
    >> Share

  808. BODEN WE, Mancini GB
    CABG for Complex CAD: When Will Evidence-Based Practice Align With Evidence-Based Medicine?
    J Am Coll Cardiol. 2016;67:56-8.
    >> Share

  809. MILOJEVIC M, Head SJ, Parasca CA, Serruys PW, et al
    Causes of Death Following PCI Versus CABG in Complex CAD: 5-Year Follow-Up of SYNTAX.
    J Am Coll Cardiol. 2016;67:42-55.
    >> Share

  810. FARKOUH ME, Douglas PS
    The Management of Acute Chest Pain: What Lies Beyond the Emergency Department Doors?
    J Am Coll Cardiol. 2016;67:27-8.
    >> Share

  811. DEDIC A, Lubbers MM, Schaap J, Lammers J, et al
    Coronary CT Angiography for Suspected ACS in the Era of High-Sensitivity Troponins: Randomized Multicenter Study.
    J Am Coll Cardiol. 2016;67:16-26.
    >> Share

  812. LAVIE CJ, Arena R, Franklin BA
    Cardiac Rehabilitation and Healthy Life-Style Interventions: Rectifying Program Deficiencies to Improve Patient Outcomes.
    J Am Coll Cardiol. 2016;67:13-5.
    >> Share

  813. STONE GW, Hochman JS, Williams DO, Boden WE, et al
    Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.
    J Am Coll Cardiol. 2016;67:81-99.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016